好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | P11 - Poster Session 11

Wednesday 04/09/25
08:00 AM - 09:00 AM PDT Add To Calendar
San Diego Convention Center | Exhibit Hall A
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology, Cerebrovascular Disease and Interventional Neurology, Headache, Movement Disorders, Epilepsy/Clinical Neurophysiology (EEG), Multiple Sclerosis, Child Neurology and Developmental Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Infectious Disease, Autoimmune Neurology, Neuro Trauma and Critical Care
View the latest research on a variety of topics. Posters are available to view in-person or online.
0.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Interactive

Program Materials Program Evaluations

Event Timeline
08:00 AM - 09:00 AM PDT Abstract 1-001 - Association Between Body Mass Index, Early B-cell Repopulation and Clinical Outcomes in Multiple Sclerosis
Ahmed Abbas, MD
08:00 AM - 09:00 AM PDT Abstract 1-002 - Longitudinal Investigation of Retrograde Transsynaptic Degeneration in Multiple Sclerosis and Its Association with Clinical Characteristics and Visual Field Deficits
Abdul Jaber Tayem, MD
08:00 AM - 09:00 AM PDT Abstract 1-003 - Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course
Tjalf Ziemssen, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 1-004 - Efficacy and Safety of Ozanimod in Patients with Early Relapsing Multiple Sclerosis: Year 1 Interim Analysis of the ENLIGHTEN Study
Andrew Choma
08:00 AM - 09:00 AM PDT Abstract 1-005 - Matching-adjusted Indirect Comparisons of Diroximel Fumarate, Ocrelizumab, and Interferon Beta-1a
Carrie M. Hersh, DO, MSc, FAAN
08:00 AM - 09:00 AM PDT Abstract 1-006 - Five Years of Ublituximab in Relapsing Multiple Sclerosis: Additional Results from Open-label Extension of ULTIMATE I and II Studies
Bruce A. Cree, MD, PhD, MAS, FAAN
08:00 AM - 09:00 AM PDT Abstract 1-007 - Exploring the Effect of GLP-1 Agonists on Multiple Sclerosis Disease Progression
Kashmaila Ali
08:00 AM - 09:00 AM PDT Abstract 1-009 - Safety and Tolerability of a Modified Dosing Regimen of Ublituximab: Updates from the ENHANCE Study
John F. Foley, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 1-010 - Use of Systemic Hormonal Contraceptives is Associated with Faster Timed 25-foot Walk Speeds in Females with Multiple Sclerosis
Katherine Havard-Coiro, MD
08:00 AM - 09:00 AM PDT Abstract 1-011 - Escalation Treatment with Methylprednisolone Versus Immunoadsorption in MS Relapse: Results of the EMMA Trial
Florian Then Bergh, MD
08:00 AM - 09:00 AM PDT Abstract 1-012 - Progression Independent of Relapsing Biology in Multiple Sclerosis: A Real World Study
Heather Yong, MD
08:00 AM - 09:00 AM PDT Abstract 1-013 - Impact of Disease-modifying Therapies on Cognitive Function and Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Systematic Review
Marianna Leite
08:00 AM - 09:00 AM PDT Abstract 1-014 - GA Depot (Long-acting IM Injection of Glatiramer Acetate) Impact on EDSS Stability in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS)
Aaron E. Miller, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 1-015 - Impact of Oligoclonal Band Status on Initial Clinical Presentation and Progression in Relapsing-remitting Multiple Sclerosis
Said Alizada, MD
08:00 AM - 09:00 AM PDT Abstract 1-016 - Alterations in the Gut Microbiome and Gut Mucus Levels are Associated with 7T MRI Leptomeningeal Enhancement and Cortical Lesions in MS
Federico Montini
08:00 AM - 09:00 AM PDT Abstract 2-001 - Neuropathic Pain Attributed to Energy Drinks--7 Cases of Vitamin B6 toxicity
Diana M. Barratt, MD, MPH, FAAN
08:00 AM - 09:00 AM PDT Abstract 2-002 - Case of Idiopathic Spinal Cord Herniation, a Rare Underrecognized Cause of Myelopathy Presenting as Brown-Séquard Syndrome
Karen Truitt, DO
08:00 AM - 09:00 AM PDT Abstract 2-003 - Recurrent Syncope Secondary to Carotid Sinus Syndrome in a Patient with Laryngeal Cancer: A Case Report
Stephen Ronay, MD
08:00 AM - 09:00 AM PDT Abstract 2-004 - Bing-Neel Syndrome: An Atypical Complication of Waldenström Macroglobulinemia – A Case Report
Mehdi Belbraouet, MD
08:00 AM - 09:00 AM PDT Abstract 2-005 - Case Report of Familial Fatal Insomnia and Diagnostic Challenges
Arlinda Deng, MD
08:00 AM - 09:00 AM PDT Abstract 2-006 - Nitrous Oxide-Induced Vitamin B12 Deficiency and Myelopathy: A Report of Two Cases
Fahim Barmak, MD
08:00 AM - 09:00 AM PDT Abstract 2-007 - Sjogren’s Syndrome Associated Myelitis Mimicking Spinal Arteriovenous Fistula in an Elderly Male: A Case Report
Shayak Sen, MD
08:00 AM - 09:00 AM PDT Abstract 2-008 - Anton-Babinski Syndrome Secondary to Posterior Reversible Encephalopathy Syndrome
Mohammad Khasawneh, MD
08:00 AM - 09:00 AM PDT Abstract 2-009 - A Rare Presentation of LaBrune Syndrome in an Elderly Male: A Case Report
Erin M. Feinstein, DO
08:00 AM - 09:00 AM PDT Abstract 2-010 - Superficial Siderosis Presenting as Sensory Myelopathy in a Patient with Marfan Syndrome
Rishi Sharma, MD
08:00 AM - 09:00 AM PDT Abstract 2-011 - Diagnostic Challenge: An Uncommon Presentation of Neurosarcoidosis
Lincoln Darla, MD
08:00 AM - 09:00 AM PDT Abstract 2-012 - Hypereosinophilic Syndrome: A Rare Cause of Stroke in a Young Patient-A Case Report
Julie Tram, MD
08:00 AM - 09:00 AM PDT Abstract 3-001 - Relationship Between Plasma BACE1 and Cerebral Small Vascular Disease in Community Population
Ziang Pan
08:00 AM - 09:00 AM PDT Abstract 3-002 - Multi-omic Liquid Biopsy Fingerstick Blood Test Platform for Neurological Disorders: Classification of Alzheimer’s Disease, Parkinson’s Disease and Myasthenia Gravis
Monica N. Hernandez, PhD
08:00 AM - 09:00 AM PDT Abstract 3-003 - Determining Microglial Quantity and Morphology After Cessation of Air Pollution Exposure
Angela Tang-Tan, BA
08:00 AM - 09:00 AM PDT Abstract 3-005 - Social Determinants of Health in Alzheimer’s Disease Patients from Peru, Nested Study From the Peruvian Alzheimer Disease Initiative (PeADI)
Maryenela Z. Illanes-Manrique, MD, Atlantic Fellow
08:00 AM - 09:00 AM PDT Abstract 3-006 - Novel, Multilevel Community-Based Participatory Approach to Recruiting Diverse Lewy Body Dementia Family Caregivers for a National Randomized Controlled Trial
Jori Fleisher, MD, MSCE, FAAN
08:00 AM - 09:00 AM PDT Abstract 3-008 - Leveraging the Direct-to-Participant FTD Disorders Registry (FTDDR) to Enable Research on FTD Disorders
Mary Krause
08:00 AM - 09:00 AM PDT Abstract 3-009 - Challenges Facing Caregivers of Individuals Diagnosed With Frontotemporal Dementia in the United States
Grace Mausisa, RN, NP
08:00 AM - 09:00 AM PDT Abstract 3-010 - Exploring Quality of Life Impact Reported by Caregivers in the FTD Insights Survey
Devon Chenette, PhD
08:00 AM - 09:00 AM PDT Abstract 3-011 - Understanding the Experiences of Patients and Dyad Care Partners in Early Alzheimer’s Disease
Lei Lv, PhD
08:00 AM - 09:00 AM PDT Abstract 3-012 - Relapsing Remitting Rapidly Progressive Dementia Due to Cerebral Amyloid Angiopathy- Related Inflammation
Mittal S. Prajapati, MD
08:00 AM - 09:00 AM PDT Abstract 3-013 - Exploring the Neuropsychological Mechanisms in a Bilingual Individual with Aphasia and Apraxia of Speech: Evidence from a Case.
Ladan Ghazi Saidi, PhD
08:00 AM - 09:00 AM PDT Abstract 3-014 - The "Doppelganger effect:" False Recognition of Faces due to Right Frontal Lobe Tumor
Irene Malaty, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 3-016 - Apolipoprotein E e4 Allele Demographic Repartition in Patient with Early Onset Alzheimer Disease
Veronique Duguay
08:00 AM - 09:00 AM PDT Abstract 3-018 - Hypertension and Diabetes as Risk Factors for Alzheimer's Disease-related Mortality, a Retrospective Epidemiological Study
Aishwarya Koppanatham, MBBS
08:00 AM - 09:00 AM PDT Abstract 3-019 - Comparing Delirium Characteristics and Functional Outcomes in Older Adults: A Matched Study of Acute Hip Fracture vs. Non-Surgical Medical Patients
Joy Youn
08:00 AM - 09:00 AM PDT Abstract 3-020 - Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Meta-analysis Comparing Tamsulosin with PGK1 Agonists, 5-ARI, and Other a-Blockers
Samuel Luca R. Pinheiro
08:00 AM - 09:00 AM PDT Abstract 4-001 - Changes in Symptom Clusters During Post-Concussion Recovery in Athletes
Brandon S. Wright
08:00 AM - 09:00 AM PDT Abstract 4-002 - Personalized TMS to the Frontal Pole Modulates Connectivity Within a Specific Amygdala Circuit in a Patient with Persistent Post-concussion Symptoms
Hyeon Min An, PhD
08:00 AM - 09:00 AM PDT Abstract 4-003 - The ComAction Initiative: An Inclusive Population-based Observational Study on the Long-term Consequences of mTBI
Alexandre Vezina, MD
08:00 AM - 09:00 AM PDT Abstract 4-004 - Comparison of MK-6240 and Flortaucipir Tau PET for the Biological Staging of Alzheimer Disease
Marina Scop Medeiros, MD
08:00 AM - 09:00 AM PDT Abstract 4-006 - Updates from the First-in-human Phase 1 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of Vormatrigine in Healthy Participants
Silvana Frizzo, MD
08:00 AM - 09:00 AM PDT Abstract 4-007 - Pain Outcomes in Persons with Multiple Sclerosis Receiving S1PR Modulators: A Cross-sectional Study
Salvador Sierra, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 4-008 - A Phase 4, Open-label Study Evaluating the Safety and Tolerability of Once Daily Rimegepant for Episodic Migraine Prevention
Robert Fountaine
08:00 AM - 09:00 AM PDT Abstract 5-001 - Clinical Utilization of Synuclein Skin Biopsy in Tertiary Movement Disorder Clinic
Mitesh P. Lotia, MD
08:00 AM - 09:00 AM PDT Abstract 5-003 - Case Report of Uncomplicated Pregnancy and Delivery in a 28-year-old Lady with Early Onset Parkinson Disease
Julius B. Anang, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-004 - Conversion to CREXONT® in the RISE-PD Phase 3 Trial Improved Aspects of Sleep as Measured by the Parkinson’s Disease Sleep Scale-2 (PDSS-2)
Ghazal Banisadr, PhD
08:00 AM - 09:00 AM PDT Abstract 5-005 - A Randomized, Double-blind, Placebo-controlled Pilot Study of Suvorexant for Insomnia in Parkinson Disease
Daniel J. Burdick, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-006 - Sustained Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa in Parkinson's Disease: 96-week Primary Treatment Period Results from an Ongoing Open-label Extension Study
Jason L. Aldred, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-007 - Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study
Harini Sarva, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-008 - Prospective Quantitative Evaluation of Brain Iron Accumulation in Parkinson's Disease Patients Compared to REM Sleep Behavior Disorder Patients and Healthy Controls
Alexander Shtilbans, MD, PhD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-009 - A Proof-of-concept Study of TR-012001, a Nasal Levodopa, in Patients with Parkinson’s Disease with OFF Episodes, Without Dopa Decarboxylase Inhibitor
Yasuhiro Sumiyoshi
08:00 AM - 09:00 AM PDT Abstract 5-010 - Impact of CREXONT on Parkinson’s Patients’ Motor States Upon Awakening: Analysis of Patient Diary Data
Ghazal Banisadr, PhD
08:00 AM - 09:00 AM PDT Abstract 5-011 - Access to and Use of Device-aided Therapies in Parkinson's Disease in France from 2015 to 2021: The PARK-DAT Study
Manon Auffret, PhD, PharmD, DAAN
08:00 AM - 09:00 AM PDT Abstract 5-012 - Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists for Parkinson's Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Rowaid Ahmad, MBBS
08:00 AM - 09:00 AM PDT Abstract 5-013 - Response to Foslevodopa/Foscarbidopa by Sex: Post Hoc Analyses of 2 Phase 3 Clinical Studies
Okeanis Vaou, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-014 - Fecal Microbiota Transplantation in Patients with Parkinson's Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Vishnu V. Byroju, MD
08:00 AM - 09:00 AM PDT Abstract 5-015 - Initial Validity and Clinical Utility of the Moticon Insole System for Assessing Gait in Parkinson’s Disease
Deborah H. Hall, MD, PhD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-016 - Comparative Efficacy and Safety of Irreversible (Rasagiline) and Reversible (Safinamide) Monoamine Oxidase Inhibitors as Add-on Therapy for Parkinson’s Disease
Syed Ijlal Ahmed, MD, MBBS
08:00 AM - 09:00 AM PDT Abstract 5-017 - Solengepras (CVN424): A Novel GPR6 Inhibitor in Clinical Development as an Investigational Therapy for Parkinson’s Disease
Kelvin L. Chou, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-018 - Safety and Tolerability of Intranasal Insulin in Parkinson’s Disease
Julia C. Johnson, MD
08:00 AM - 09:00 AM PDT Abstract 5-019 - Motivations and Burdens of Participation in Parkinson’s Disease Clinical Trials: Experiences from a Disease-modifying Phase 2 Study
Emily Tharp, MD
08:00 AM - 09:00 AM PDT Abstract 5-020 - Opicapone Improved Parkinson’s Disease-related Sleep Disturbances: Findings from the OASIS Study
Helena Brigas, PhD
08:00 AM - 09:00 AM PDT Abstract 5-021 - Attitudes and Beliefs in Parkinson’s Disease (PD) Research Participation
Prisha Nanda Kumar, Medical Student
08:00 AM - 09:00 AM PDT Abstract 5-022 - A Noninterventional Study to Evaluate Real-world Feasibility, Compliance, and Satisfaction with Digital Health Technologies for Parkinson’s Disease
Nauman Abid, MD
08:00 AM - 09:00 AM PDT Abstract 5-023 - A Systematic Review of Fecal Matter Transplant and Its Impact on Levodopa Metabolism and Gastrointestinal Function in Parkinson’s Disease
Apurva H. Patel, MD
08:00 AM - 09:00 AM PDT Abstract 5-024 - Use of Virtual Reality-based Exergames in Patients with Parkinson’s Disease: A Systematic Review and Meta-analysis
Artur Menegaz de Almeida, MS
08:00 AM - 09:00 AM PDT Abstract 5-026 - Staged, Bilateral MR-guided Focused Ultrasound Pallidothalamic Tractotomy as a Treatment for Movement Disorders: Rationale and Design of a Parkinson’s Disease Study
Arif Dalvi, MD
08:00 AM - 09:00 AM PDT Abstract 5-027 - Continuous Subcutaneous Apomorphine Infusion for Parkinson Disease Motor Fluctuations: Long-term Data from the Ongoing InfusON Extension Study
Peter A. LeWitt, MD
08:00 AM - 09:00 AM PDT Abstract 5-028 - Improvement in Uninterrupted Good ON Time and Reduction in OFF Periods with CSAI Treatment
Daniel Kremens, MD, JD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-029 - Patient Experiences Initiating Continuous Subcutaneous Apomorphine Infusion (CSAI): An Interview-based Survey of InfusON Study Participants
Pinky H. Agarwal, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 5-030 - The Safety and Efficacy of Subcutaneous Forms of Levodopa/Carbidopa (ND0612 and Foslevodopa/ Foscarbidopa) on Parkinson’s Disease Patients: Systematic Review and Meta Analysis
Ram K. Saha, MD
08:00 AM - 09:00 AM PDT Abstract 5-031 - Lived Experiences Within the First Year of a Parkinson's Disease Diagnosis: The Patient Voice Using Verbatim-reported Symptoms
Surabhi A. Garg, MD
08:00 AM - 09:00 AM PDT Abstract 6-001 - High Rates of Discontinuation of D2 Receptor Antagonists as First-Line Treatment of Tourette Syndrome in Children: A Retrospective Database Analysis
Kinga Tomczak, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 6-002 - Changes in Metabolic Parameters and Determination of Minimal Clinically Important Difference in YGTSS-TTS Using Data From the Randomized Phase 2b and Open-Label Extension Studies of Ecopipam For Tourette Syndrome
Donald Gilbert, MD, FAAN
08:00 AM - 09:00 AM PDT Abstract 6-004 - The Landscape of Inpatient Pediatric Status Dystonicus Over 4.5 Years at The Hospital for Sick Children in Canada
Lindsey Vogt, MD
08:00 AM - 09:00 AM PDT Abstract 6-005 - Clinical Profile of Newly Diagnosed Children With Tourette Syndrome: Observational Cohort Study of a Large Electronic Medical Records Database
Kinga Tomczak, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 6-006 - Five-Year Follow-Up on Natural History of Benign Paroxysmal Torticollis
Joanne Crandall
08:00 AM - 09:00 AM PDT Abstract 6-007 - Expanding Our Understanding of Dystonia in Cerebral Palsy: Learning from Caregiver Experts
Laura Gilbert, DO, MBA
08:00 AM - 09:00 AM PDT Abstract 6-008 - Temporal Trends in Cerebral Palsy-Related Mortality in the United States: A 1999-2020 Analysis
Shayan Marsia, MBBS
08:00 AM - 09:00 AM PDT Abstract 6-009 - “Ear of Lynx Sign” - A Radiodiagnostic clue for Complicated Hereditary Spastic Paraplegia: A Familial Case Report
Muhammad A. Khawaja, MBBS
08:00 AM - 09:00 AM PDT Abstract 6-010 - Deep Brain Stimulation for a DYT-TOR1A Variant Presenting with Rapidly Progressive Refractory Status Dystonicus in a 3-year-old
Audrey Hunt, DO
08:00 AM - 09:00 AM PDT Abstract 6-011 - Upper Limb Impairments are Common in Pediatric Hereditary Spastic Paraparesis
Michelle R. Christie, MD
08:00 AM - 09:00 AM PDT Abstract 6-012 - A Case Report of Infant-Type Hemispheric Glioma with a novel PPP1CB-ALK Kinase Fusion and Response to Lorlatinib
Harshdeep Kaur, DO
08:00 AM - 09:00 AM PDT Abstract 6-013 - Paraspinal Ganglioneuroblastoma presenting with Isolated Ataxia in a Child
Xiaoting Wang, MD
08:00 AM - 09:00 AM PDT Abstract 6-014 - Post-Resection Catatonia in a Pediatric Patient with Choroid Plexus Carcinoma
Abhijit R. Das, MD
08:00 AM - 09:00 AM PDT Abstract 6-015 - Mesenchymal Chondrosarcoma Presenting as Atypical Brown-Sequard Syndrome in a Healthy Teenager
Naman D. Shah, MD
08:00 AM - 09:00 AM PDT Abstract 6-016 - Epileptic Seizures Revealing Tuberous Sclerosis of Bournville in a Tropical Environment: A Study of 12 Case Series
Mamadou Diallo, MD
08:00 AM - 09:00 AM PDT Abstract 6-017 - Effectiveness of Zonisamide Prophylaxis in Reducing Headache Days per Month for Pediatric Migraine Patients, A Retrospective Analysis
Isabelle H. Kang
08:00 AM - 09:00 AM PDT Abstract 6-018 - HaNDLing the Unknown: A Rare Case of Pediatric Headache
Maria Gonzalez, MD
08:00 AM - 09:00 AM PDT Abstract 6-019 - Unraveling Pediatric RCVS: A Hidden Cause of Headaches and Infarcts
Maria Gonzalez, MD
08:00 AM - 09:00 AM PDT Abstract 6-020 - Child’s First Migraine Confused for Concussion
Chimaobi Ochulo
08:00 AM - 09:00 AM PDT Abstract 7-001 - Sex-based Differences in the Clinical Presentation and Outcomes of Posterior Reversible Encephalopathy Syndrome: A Nationwide Analysis
Prince K. Pekyi-Boateng, MBBS
08:00 AM - 09:00 AM PDT Abstract 7-003 - Posterior Reversible Encephalopathy Syndrome (PRES) Associated with Profound Vitamin C Deficiency
Santiago Martinez Sosa, MBBS
08:00 AM - 09:00 AM PDT Abstract 7-005 - Analyzing the Neurophysiologic Effects of IA Verapamil During Angiographic Treatment of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Rafael Maarek
08:00 AM - 09:00 AM PDT Abstract 7-006 - Determinants of Successful External Ventricular Drain Weaning and Removal in Nontraumatic Subarachnoid Hemorrhage Patients
Shane Musick, MD
08:00 AM - 09:00 AM PDT Abstract 7-007 - Evaluating the Effects of Intrathecal Nicardipine Vasospasm Treatment on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage
Diana Wang
08:00 AM - 09:00 AM PDT Abstract 7-008 - Efficacy and Adverse Effects of Induced Hypertension for Vasospasm in Subarachnoid Hemorrhage: A Systematic Review
Namal Seneviratne, MD
08:00 AM - 09:00 AM PDT Abstract 7-009 - A Case of Meningoencephalitis Presenting with Pseudo-subarachnoid Hemorrhage (pSAH) and Vasculopathy
Nora Nikprelevic, MD, MBBS
08:00 AM - 09:00 AM PDT Abstract 7-010 - A Ticking Time Bomb: The Rapid Development of Subdural Empyema and Herniation Syndrome
Alejandro M. Blaubach, MD
08:00 AM - 09:00 AM PDT Abstract 8-001 - In-Hospital Mortality, Length of Stay, and Discharge Outcomes Among Patients with Transverse Myelitis: A National Inpatient Sample Database Analysis
Muhammad Sohaib, MBBS
08:00 AM - 09:00 AM PDT Abstract 8-002 - Novel FLAMES Presentation in Anti-MOG Encephalitis with FLAIR-Hyperintense Lesions
Jairo A. Gaitan Alfonso, MD
08:00 AM - 09:00 AM PDT Abstract 8-003 - Association of Roquin-1 and Tfh cells with Clinical Characteristic in Neuromyelitis Optica
Hui Li
08:00 AM - 09:00 AM PDT Abstract 8-004 - Anti-SRP Necrotizing Myopathy in Association with Neuromyelitis Optic Spectrum Disorder
Shemonti Hasan, MD
08:00 AM - 09:00 AM PDT Abstract 8-005 - The Frequency of Optic Disc Hemorrhages and Other Retinal Findings on Fundoscopic Examination in Acute MOGAD Optic Neuritis
Nanthaya Tisavipat, MD
08:00 AM - 09:00 AM PDT Abstract 8-006 - Dynamic Optic Nerve MRI Changes in Acute Optic Neuritis in MOG Antibody-Associated Disease
Stephanie Syc-Mazurek, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 8-007 - Efficacy and Safety of Inebilizumab Among Non-White Demographic Groups with Neuromyelitis Optica Spectrum Disorder: N-MOmentum Study Subgroup Analysis
Friedemann Paul
08:00 AM - 09:00 AM PDT Abstract 8-008 - Improvements in Pain and Disability Contribute to Improved Quality of Life After Inebilizumab Treatment in Attack-Free Neuromyelitis Optica Spectrum Disorder (NMOSD) Participants
Orhan Aktas, MD
08:00 AM - 09:00 AM PDT Abstract 8-009 - Neighborhood Disadvantage is Not Associated with Exposure to NMOSD Treatment
Kaitlyn Palmer, MD
08:00 AM - 09:00 AM PDT Abstract 8-010 - Socioeconomic Status and Its Impact on Clinical and Radiographic Findings in MOGAD at Diagnosis
Amna M. Ali, BA
08:00 AM - 09:00 AM PDT Abstract 8-011 - Time to Vaccination After Rituximab (RTX) Discontinuation in Patients with anti–Aquaporin–4 Antibody–Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): A Post-Hoc Analysis of the CHAMPION-NMOSD Trial
Jeffrey L. Bennett, MD, PhD, FAAN
08:00 AM - 09:00 AM PDT Abstract 8-012 - A Real-World Study of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder
Mengcui Gui
08:00 AM - 09:00 AM PDT Abstract 8-013 - NMO SPOTLIGHT Registry: Real-World Clinical Outcomes With Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)
Ahmed Z. Obeidat, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 8-014 - Investigation of the Prognostic Improvement Effects of Therapeutic Apheresis for Neuromyelitis Optica Spectrum Disorder: A Single-center Case Series
Wataru Horiguchi, MD
08:00 AM - 09:00 AM PDT Abstract 8-016 - Adherence to Biologic Therapies Among Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States
Bruce A. Cree, MD, PhD, MAS, FAAN
08:00 AM - 09:00 AM PDT Abstract 8-017 - A Case Report of NMOSD Hidden Beneath MG and Cervical Spondylosis with Imaging Changes of Cervical Cord Compression: The Dual Therapeutic Effect of Inebilizumab
Ying Huang
08:00 AM - 09:00 AM PDT Abstract 8-018 - Aquaporin-4 IgG Positive Neuromyelitis Optica Spectrum Disorder: Frequency and Type of Cancer Co-Existence, Antigen Expression and Proof of Paraneoplastic Phenotype
Naga Pradyumna Kothapalli, MD
08:00 AM - 09:00 AM PDT Abstract 8-019 - Frequency of the Supporting Features for MOGAD Diagnosis in Patients with Multiple Sclerosis
Pietro Zara, MD
08:00 AM - 09:00 AM PDT Abstract 8-020 - Pregnancy Outcomes in Neuromyelitis Optica Spectrum Disorder: A Meta-Analysis of Pharmacotherapeutic Agents
Maziar Eslami, MD
08:00 AM - 09:00 AM PDT Abstract 9-002 - Assessing the Association Between Immune Dysfunction Conditions and Epilepsy: An Analysis of the 2021 National Health Interview Survey Data
Aseel A. Alamri
08:00 AM - 09:00 AM PDT Abstract 9-003 - Discovery of a Novel Likely Pathogenic Splice Site Variant of PACS1 in a Patient with Craniofacial Deformity, Developmental Delay, and Drug-Resistant Epilepsy
Ning Zhong, MD
08:00 AM - 09:00 AM PDT Abstract 9-004 - Meta Analysis and Case review of Clinical, Neuro anatomical and Electrophysiological Characteristics of Patients with Musicogenic Epilepsy.
Hira Burhan, MD
08:00 AM - 09:00 AM PDT Abstract 9-005 - Depressive Symptoms are Associated with APOE4 Carrier Status and Anti-Seizure Medication Polytherapy in Late-Onset Unexplained Epilepsy
Michael Sadek
08:00 AM - 09:00 AM PDT Abstract 9-006 - Retrospective Analysis of Skull Base Defects and Prevalence and Characteristics of Related Epilepsy
John K. Whalen, DO
08:00 AM - 09:00 AM PDT Abstract 9-008 - Dissecting the Phenotype of CHD2-Associated Epilepsy: A Systematic Review and Individual Participant Data Analysis
Anabel Puri
08:00 AM - 09:00 AM PDT Abstract 9-009 - Exploring the Role of SCN1A in Temporal Lobe Epilepsy: A Systematic Review of Associations and Clinical Implications
Azhar Said, MD
08:00 AM - 09:00 AM PDT Abstract 9-010 - Yield of Epilepsy Gene Panel Testing Among Adult and Pediatric Patients at a Regional Academic Medical Center
Marissa Kellogg, MD, MPH, FAAN
08:00 AM - 09:00 AM PDT Abstract 9-011 - Adult Absence Seizures: A Two-Center Cohort Study
Irving Fuentes
08:00 AM - 09:00 AM PDT Abstract 9-012 - Epilepsy with Eyelid Myoclonia: Should Focal Seizures Exclude the Diagnosis?
Lorraine Siebold, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 9-013 - Post-Encephalitic Epilepsy: Incidence, Characteristics, and Risk Factors
Melissa Canales
08:00 AM - 09:00 AM PDT Abstract 9-014 - Novel CHD2 Gene Deletion in a Patient with Epilepsy and Neurodevelopmental Disorders
Said El Hage, MD
08:00 AM - 09:00 AM PDT Abstract 9-015 - Monocular Epileptic Opsoclonus in a Patient with Alternating Hemiplegia of Childhood and ATP1A3 Mutation
Margil Ranpariya, MBBS
08:00 AM - 09:00 AM PDT Abstract 9-016 - Alternative Splicing of Kv7.2 and Kv3.3: Insights into Seizure Disorders and Spinocerebellar Ataxia Type-13
Md Mostafizur Rahman, MBBS, MS
08:00 AM - 09:00 AM PDT Abstract 9-017 - Epilepsy with Developmental Delay and Intellectual Disabilities – Clinical, Radiographic, Electroencephalographic Features in Adults with Epilepsy
Gulbudin Muhammad, MD
08:00 AM - 09:00 AM PDT Abstract 10-001 - Neurobrucellosis Presenting with Parkinsonism and Psychiatric Manifestations: Two Cases from Saudi Arabia
Moneera Aldraihem, MBBS
08:00 AM - 09:00 AM PDT Abstract 10-002 - Longitudinally Extensive Transverse Myelitis Secondary to Brucella Infection: A Rare Neurological Complication
Mohammed Qussay Ali Al-Sabbagh, MD
08:00 AM - 09:00 AM PDT Abstract 10-003 - Persistence of Cutibacterium acnes for Nine Years in a Host With a Cranial Implant
Emily White, MD
08:00 AM - 09:00 AM PDT Abstract 10-004 - The Impact of Brain MRI on the Management of Infective Endocarditis (IE) at a Large Urban Safety-Net Hospital
Meha Prabhu
08:00 AM - 09:00 AM PDT Abstract 10-005 - An Uncommon “Great Imitator” - Long Term Neurological Manifestations of Recurrent Whipple Disease
Maria Andreina Hernandez, MD
08:00 AM - 09:00 AM PDT Abstract 10-006 - Unveiling the Uncommon: A Rare case of Quadraparesis in the Setting of Mycoplasma Pneumonia Infection Associated with Brain and Spinal Cord Demyelination
Jorge Beovides Vazquez, DO
08:00 AM - 09:00 AM PDT Abstract 10-007 - From the Deli to the ICU: Listeria Rhombencephalitis and Brainstem Abscess
Kimberly Chieh
08:00 AM - 09:00 AM PDT Abstract 10-008 - Listeria Brain Abscess Resembling Acute Stroke: A Case Report
Swanny Shi
08:00 AM - 09:00 AM PDT Abstract 11-001 - Timed Up-and-Go (TUG) Test in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
James Hiana, MD
08:00 AM - 09:00 AM PDT Abstract 11-002 - Case Report: Amyotrophic Lateral Sclerosis (ALS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Coexistence in a Patient with C9orf72 Mutation
Rowaid Ahmad, MBBS
08:00 AM - 09:00 AM PDT Abstract 11-003 - Recurrent Facial Nerve Palsy and Chronic Inflammatory Demyelinating Polyneuropathy Due to Anti-GQ1b Antibody
Karim Makhoul, Sr., MD
08:00 AM - 09:00 AM PDT Abstract 11-004 - Two Cases of HNPP Masquerading as CIDP
Mark Jedras, DO
08:00 AM - 09:00 AM PDT Abstract 11-005 - Chronic Immune Demyelinating Polyradiculoneuropathy in Charcot-Marie-Tooth Disease: Two Cases and Insights on Diagnosis
Alaina Giacobbe, MD
08:00 AM - 09:00 AM PDT Abstract 11-006 - Juvenile ALS Masquerading as an Acquired Inflammatory Neuropathy
Whitney Franklin, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 11-008 - Sex-specific Cognitive Differences in ALS
Maurizio Grassano, MD
08:00 AM - 09:00 AM PDT Abstract 11-009 - Survey of ALS Centers Shows Variability and Opportunity for International Ventilatory Support for Patients with ALS
Eufrosina I. Young, MD
08:00 AM - 09:00 AM PDT Abstract 11-010 - Remote Multi-modal Monitoring in ALS Using Wearable and Digital Assessments
Ashkan Vaziri, PhD
08:00 AM - 09:00 AM PDT Abstract 11-011 - Preliminary Analysis of the FACIT-COST Scale Among People Living with Amyotrophic Lateral Sclerosis (ALS)
Terry D. Heiman-Patterson, MD
08:00 AM - 09:00 AM PDT Abstract 11-012 - Beyond the Eye: AI-enhanced Visual Biomarker Discovery and Tracking for Amyotrophic Lateral Sclerosis
Zachary Bides
08:00 AM - 09:00 AM PDT Abstract 11-014 - Self-replicating Proteins: Final Common Pathways Leading to the Occurrence of Sporadic ALS
Richard A. Smith, MD
08:00 AM - 09:00 AM PDT Abstract 11-017 - Nusinersen Treatment in Spinal Muscular Atrophy Type 3: Real-life Experience from a Single Center in Türkiye
Arman Cakar
08:00 AM - 09:00 AM PDT Abstract 11-018 - Risdiplam: Therapeutic Effects and Tolerability in a Small Cohort of 6 Adult Type 2 and Type 3 SMA Patients
Edoardo Malfatti, MD
08:00 AM - 09:00 AM PDT Abstract 11-019 - Genotypic-Phenotypic Correlation in HSP patients
Vijaya Mishra, MD, MBBS, DM
08:00 AM - 09:00 AM PDT Abstract 11-020 - Clinical Outcomes of Adult Spinal Muscular Atrophy Patients on Appropriate Pharmaceutical Interventions: A Retrospective Chart Review
Rachel L. Schuurs, MD
08:00 AM - 09:00 AM PDT Abstract 11-021 - Investigating the Female Protective Effect in ALS: Insights from an Italian Cohort
Maurizio Grassano, MD
08:00 AM - 09:00 AM PDT Abstract 11-022 - A Clinical Experience with Neurofilament Light Chain as a Biomarker in ALS: Ready for Use as Inclusion Criteria for Clinical Trials?
Dennis Huang, MD
08:00 AM - 09:00 AM PDT Abstract 11-023 - Real-world Assessment of Neurofilament Light Chain Levels in ALS and Other Neuronal Disorders
Gabriella Law
08:00 AM - 09:00 AM PDT Abstract 11-024 - Diagnostic Value of Cerebral Peduncle Diameter in Amyotrophic Lateral Sclerosis Using Transcranial Ultrasound
Aida Akhoundi, MD
08:00 AM - 09:00 AM PDT Abstract 11-027 - Genetically Mediated ALS: Genotype-Phenotype Correlation and Disease Outcome in an Indian Cohort
Muddasu Suhasini Keerthipriya, MBBS
08:00 AM - 09:00 AM PDT Abstract 11-028 - Clinical and Molecular Landscape of Amyotrophic Lateral Sclerosis Patients with OPTN Variants from Turkey and Possible Therapeutic Response to Inhibation of RIPK1
Hacer Durmus, MD
08:00 AM - 09:00 AM PDT Abstract 11-029 - The Safety and Efficacy of Arimoclomol in Amyotrophic Lateral Sclerosis: A Systematic Review
Emanuelly L. Barbosa
08:00 AM - 09:00 AM PDT Abstract 11-030 - Safety of Arimoclomol in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Rowaid Ahmad, MBBS
08:00 AM - 09:00 AM PDT Abstract 11-031 - Efficacy and Safety of Efgartigimod in the Treatment of Amyotrophic Lateral Sclerosis (ALS): A Retrospective Cohort Study
XIAOLI YAO, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 11-032 - GLP-1-related Antihyperglycemic Medication Use is Associated with Shorter Survival in Patients with Amyotrophic Lateral Sclerosis and Diabetes Mellitus
Ikjae Lee, MD
08:00 AM - 09:00 AM PDT Abstract 11-033 - Role of Seizures in Behavioral Deficits and Neurodegeneration in rNLS8 Mice
Jaskeerat Gujral, BA
08:00 AM - 09:00 AM PDT Abstract 11-034 - Abnormal Undulating Tongue Movements Attributed to Delayed Post Radiation Myokymia
Patrick J. Bergquist, MD
08:00 AM - 09:00 AM PDT Abstract 12-001 - The Prevalence of Visual Snow and Visual Snow Syndrome in the Pediatric Population.
Brandon M. Jones, MD
08:00 AM - 09:00 AM PDT Abstract 12-003 - Correlation of Medication Overuse with Headache Frequency and Intensity in Patients with Idiopathic Intracranial Hypertension
Steven J. Roman Troche, MD
08:00 AM - 09:00 AM PDT Abstract 12-004 - ECHOing Innovation: Improving Migraine Outcomes in Community Neurology Clinics
Natalie Sanfratello, MPH
08:00 AM - 09:00 AM PDT Abstract 12-005 - Awareness for SMART Syndrome (Stroke-Like Migraine Attacks After Radiation Therapy), a Rare and Delayed Complication of Cranial Irradiation: A Case Report with Literature Review
Shiv K. Jha, MBBS
08:00 AM - 09:00 AM PDT Abstract 12-006 - Headache in a Case of Tuberculosis: Think Beyond Meningitis
Anand Kumar, MD, DM
08:00 AM - 09:00 AM PDT Abstract 12-008 - From SUNCT-like Symptoms to Lyme Neuroborreliosis: A Misleading Headache Presentation.
Alisha Qaiser, MD
08:00 AM - 09:00 AM PDT Abstract 12-009 - Frequency of Abnormal Neurological Examinations in a Subspecialty Headache Clinic: A Retrospective Chart Review
Sabrina Leung
08:00 AM - 09:00 AM PDT Abstract 12-010 - The use of the Traffic Light of Migraine Action Plan (TRALI-MAP) in Acute Migraine Treatment
James Im, MD
08:00 AM - 09:00 AM PDT Abstract 13-001 - The Ultimate Stroke Scale (USS): An Innovative Tool for Automated Large Vessel Occlusion Screening
Sachin A. Kothari, MD
08:00 AM - 09:00 AM PDT Abstract 13-002 - Trends in Non-Traumatic Acute Subdural Hemorrhage Mortality in the U.S.: A Retrospective Analysis
Isra Masood, MBBS
08:00 AM - 09:00 AM PDT Abstract 13-003 - Computed Tomography Perfusion Imaging Profiles Are Similar Before and After Transfer to a Comprehensive Stroke Center
Esam Abobaker, DO
08:00 AM - 09:00 AM PDT Abstract 13-005 - Outcomes of Reperfusion Therapies for Acute Ischemic Stroke in Patients with Pre-existing Dementia
Arjun K. Rangan, MD
08:00 AM - 09:00 AM PDT Abstract 13-006 - Spatial Brain Health Patterns in Vascular Territories Differentially Affect Functional Outcomes in Acute Ischemic Stroke
Markus D. Schirmer, PhD
08:00 AM - 09:00 AM PDT Abstract 13-009 - GO-SCAN: A Scoring System for Signs and Symptoms of Maternal Stroke
Catherine G. Shang, MD
08:00 AM - 09:00 AM PDT Abstract 13-012 - Assessing the Accuracy of Stroke Code Activations at a Municipal Hospital Using a Validated Tool
Sungita Kumar, MD
08:00 AM - 09:00 AM PDT Abstract 13-013 - Identifying the Neuroanatomy of Sensory Processing Disorders: Lesion Network Mapping of Altered Auditory and Somatosensory Processing
Shreya Tripathy
08:00 AM - 09:00 AM PDT Abstract 13-014 - Intravenous Tirofiban in Acute Ischemic Stroke Patients Not Receiving Reperfusion Treatments: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Shatha S. Alqurashi
08:00 AM - 09:00 AM PDT Abstract 13-015 - Infratentorial Cerebral Microbleeds and Incident Dementia: The ARIC-Neurocognitive Study
Richard Q. Vuong
08:00 AM - 09:00 AM PDT Abstract 13-017 - Efficacy and Safety of Endovascular Thrombectomy with or without Thrombolysis in Acute Basilar Artery Occlusion: A Meta-analysis of Randomized and Non-Randomized Studies
Muhammad W. Ansari, MD
08:00 AM - 09:00 AM PDT Abstract 13-018 - Assessment of the Prevalence, Risk Factors and Outcomes of Large Vessel Occlusion Strokes at the University Teaching Hospitals, Lusaka, Zambia
Musisye Luchembe
08:00 AM - 09:00 AM PDT Abstract 13-020 - Stroke in the Young - Are we Missing the Target?
Ramsey Amoudi, MS
08:00 AM - 09:00 AM PDT Abstract 14-001 - Spontaneous Branch Retinal Artery and Central Retinal Vein Occlusion with Sickle Cell Trait: A Case Report
Michael Kmeid, MD
08:00 AM - 09:00 AM PDT Abstract 14-002 - Navigating the Complexities of CNS vasculitis
Alexander Vorobyev, MD
08:00 AM - 09:00 AM PDT Abstract 14-003 - Inflammatory Bowel Disease and Stroke: Exploring the Hidden Vascular Risks
Abdallah Khan, MBBS
08:00 AM - 09:00 AM PDT Abstract 14-004 - An Unusual Presentation of Takayasu’s Arteritis in the Community Setting
Shital Patel, MD
08:00 AM - 09:00 AM PDT Abstract 14-005 - Fulminant Neutrophilic Vasculitis of the Central Nervous System
Camille Barbour, MD
08:00 AM - 09:00 AM PDT Abstract 14-006 - A Devastating Detour: When Immune Checkpoint Inhibitors Triggers CNS Vasculitis
Abhiram Parameswaran, MBBS
08:00 AM - 09:00 AM PDT Abstract 14-007 - Internal Carotid Artery Thrombus in the Setting of Iron Deficiency Anemia and Thrombocytosis: A Case Series
Allison Muha, MD
08:00 AM - 09:00 AM PDT Abstract 14-008 - Blood, Heart, and Mind: A Case of Lymphoma-Triggered Antiphospholipid Syndrome Leading to Recurrent Embolic Strokes
Mohammed Qussay Ali Al-Sabbagh, MD
08:00 AM - 09:00 AM PDT Abstract 14-009 - Acute Ischemic Stroke Associated with May-Thurner Syndrome: A Hypothesis-Generating Case Review
Matthew C. Loftspring, MD, PhD
08:00 AM - 09:00 AM PDT Abstract 14-011 - A diagnostic dilemma: Subacute Encephalopathy and Seizure in Alcoholics (SESA) vs Seronegative Autoimmune Encephalitis
Avinash S. Kolli, MD
08:00 AM - 09:00 AM PDT Abstract 14-012 - Case Report: Cerebral Infarction Following Hemophilus Influenzae Meningitis (HfluM) in a Vaccinated Elderly Female
Kiana Moussavi, MD
08:00 AM - 09:00 AM PDT Abstract 14-013 - Spinal Cord Infarcts with Misleading Inflammatory Findings: A Case Series Illustrating the Importance of Delayed Diffusion Imaging with Spinal MRI and Understanding of the Natural History of a Rare Pathology
Nora Ko, MD
08:00 AM - 09:00 AM PDT Abstract 14-014 - Ischemic Stroke In Coccidioides Meningitis-Related Vasculitis in a Non-endemic Region
Marcus Milani
08:00 AM - 09:00 AM PDT Abstract 14-015 - Utility of the Hypercoagulable Panel in Decision Making for Cryptogenic Stroke and Patent Foramen Ovale
Riana Schleicher
08:00 AM - 09:00 AM PDT Abstract 14-016 - Unresponsive and Undiagnosed: A Journey Through SAG Meningitis and AOP Stroke
FNU Shivangi, MBBS
Faculty Disclosures
Ziang Pan Mr. Pan has nothing to disclose.
Jun Ni Jun Ni has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Zi-Yue Liu Zi-Yue Liu has nothing to disclose.
Fei Han Fei Han has nothing to disclose.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Ding-Ding Zhang Ding-Ding Zhang has nothing to disclose.
Sachin A. Kothari, MD Dr. Kothari has nothing to disclose.
Rami Morsi, MD Dr. Morsi has nothing to disclose.
Olivia Kozel, BA Miss Kozel has nothing to disclose.
Harsh Desai, MD Dr. Desai has nothing to disclose.
Archit B. Baskaran, MD Dr. Baskaran has nothing to disclose.
Neha Sehgal, DO Dr. Sehgal has nothing to disclose.
Okker Verhagen Metman, DO Dr. Verhagen Metman has nothing to disclose.
Matthew M. Smith, MD Dr. Smith has nothing to disclose.
James E. Siegler III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Elisheva R. Coleman, MD Dr. Coleman has nothing to disclose.
James R. Brorson, MD Dr. Brorson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Peer Review Corporation. Dr. Brorson has a non-compensated relationship as a Vascular Neurology Pilot Committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Shyam Prabhakaran, MD Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Tareq Kass-Hout, MD Dr. Kass-Hout has nothing to disclose.
Ahmad Chahine, MD Dr. Chahine has nothing to disclose.
Michael Kmeid, MD Dr. Kmeid has nothing to disclose.
Elena Schmidt, MD Dr. Schmidt has nothing to disclose.
Kamleshun Ramphul Kamleshun Ramphul has nothing to disclose.
Renuka Verma Renuka Verma has nothing to disclose.
Maya Gabel, MD Dr. Gabel has nothing to disclose.
Conor T. Flavin, MD Dr. Flavin has nothing to disclose.
Fiifi Duodu, MD Dr. Duodu has nothing to disclose.
Prince K. Pekyi-Boateng, MBBS Dr. Pekyi-Boateng has nothing to disclose.
Nana Boakye Agyeman Badu-Prempeh, MD Ms. Badu-Prempeh has nothing to disclose.
Brandon M. Jones, MD Dr. Jones has nothing to disclose.
Carrie E. Robertson, MD, FAAN Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apeya. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Robertson has received research support from Biohaven/Pfizer. Dr. Robertson has received publishing royalties from a publication relating to health care. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Research consultant with University of Minnesota.
Chia-Chun Chiang, MD Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene Corporation . Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. The institution of Dr. Chiang has received research support from American Heart Association. The institution of Dr. Chiang has received research support from Lundbeck. The institution of Dr. Chiang has received research support from Pfizer.
Kenneth J. Mack, MD, PhD, FAAN Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVie. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. Dr. Mack has received publishing royalties from a publication relating to health care.
Paul E. Youssef, DO Dr. Youssef has nothing to disclose.
James Hiana, MD Dr. Hiana has nothing to disclose.
Karissa Gable, MD, FAAN Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accordant. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazenca. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols . Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for annexon. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Jeffrey A. Allen, MD Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson.
Mohammad T. Abuawwad Dr. Abuawwad has nothing to disclose.
Yomna W. W. Mahmoud, MBBS Dr. Mahmoud has nothing to disclose.
Mohammad Jehad J. Taha Dr. Taha has nothing to disclose.
Yara A. Eltobgi, PhD Miss Eltobgi has nothing to disclose.
Khaled J. Ghanayem II, MD Dr. Ghanayem has nothing to disclose.
Moneeb M. Al-taj, Jr., MD Dr. Al-taj has nothing to disclose.
Shahd Al Haj Ali, MD Dr. Al Haj Ali has nothing to disclose.
Khalid M. Ahmed, MBBS Dr. Ahmed has nothing to disclose.
Hadil W. Alswaitti, Jr., MBBS Ms. Alswaitti has nothing to disclose.
Mohammad Aladawi, MD Dr. Aladawi has nothing to disclose.
Moneera Aldraihem, MBBS Dr. Aldraihem has nothing to disclose.
Mohammed A. AlShareet, MBBS Dr. AlShareet has nothing to disclose.
Thamer S. Alhowaish, MD Dr. Alhowaish has nothing to disclose.
Mazen S. Alamr, MBBS Dr. Alamr has nothing to disclose.
Omar A. Alsinaidi, MD Dr. Alsinaidi has nothing to disclose.
Abdulrahman Ali No disclosure on file
Hisham Aldhukair, MBBS Dr. Aldhukair has nothing to disclose.
Anaiya M. Crutchfid, student Ms. Crutchfid has nothing to disclose.
Nigam Reddy, RN, NP Mr. Reddy has nothing to disclose.
Anwar Ahmed, MD, FAAN Dr. Ahmed has nothing to disclose.
Mitesh P. Lotia, MD Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphalan. Dr. Lotia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott.
Brandon S. Wright Mr. Wright has nothing to disclose.
Matthew T. Lorincz, MD, PhD Dr. Lorincz has received personal compensation for serving as an employee of Alexion. Dr. Lorincz has received personal compensation for serving as an employee of Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Lorincz has received research support from Alexion.
James T. Eckner, MD An immediate family member of Dr. Eckner has received personal compensation for serving as an employee of Autism Alliance of Michigan. The institution of Dr. Eckner has received research support from NIH. The institution of Dr. Eckner has received research support from Department of Defense. Dr. Eckner has received intellectual property interests from a discovery or technology relating to health care. Dr. Eckner has received personal compensation in the range of $500-$4,999 for serving as a CARE Consortium Publication Committee Member with Indiana University. Dr. Eckner has received personal compensation in the range of $0-$499 for serving as a 好色先生al Content Contributor with Move United.
Mark T. Roberts, MD Dr. Roberts has nothing to disclose.
Abigail Bretzin, PhD The institution of Dr. Bretzin has received research support from Ivy League Big Ten University Presidents.
Michael Popovich, MD Dr. Popovich has nothing to disclose.
Diana M. Barratt, MD, MPH, FAAN Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Vlantis Law, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Traub Lieberman. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Callahan Fusco. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Chane Socarras. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conroy Simberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Crandall & Katt. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelley Kronenberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Plakas Mannos. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marshall Denehey. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pritt & Spano. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Russo Law.
Madhureeta Achari, MD, FAAN Dr. Achari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKinney-Taylor.
Muhammad Sohaib, MBBS Mr. Sohaib has nothing to disclose.
Syed Haris Ahmed, MBBS Dr. Ahmed has nothing to disclose.
Muhammad Ahmed, MD Dr. Ahmed has nothing to disclose.
Muhammad Tayyab Muzaffar Chaychi, MD Muhammad Tayyab Muzaffar Chaychi, MD has nothing to disclose.
Hafiz M. Maaz Mr. Maaz has nothing to disclose.
Haris Kamal, MD Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Kinga Tomczak, MD, PhD The institution of Dr. Tomczak has received research support from Emalex Biosciences, Inc.. Dr. Tomczak has a non-compensated relationship as a collabolator with Emalex Biosciences, Inc. that is relevant to AAN interests or activities.
Jason P. Swindle, PhD, MPH Mr. Swindle has nothing to disclose.
Firas Dabbous, PhD Dr. Dabbous has received personal compensation for serving as an employee of Thermofisher Scientific.
George Karkanias, PhD Dr. Karkanias has received personal compensation for serving as an employee of Emalex Biosciences, Inc.
Sarah Atkinson Sarah Atkinson has received personal compensation for serving as an employee of Emalex Biosciences. Sarah Atkinson has received personal compensation for serving as an employee of World Wide Clinical Trials.
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Faizan Mazhar, PhD Dr. Mazhar has received personal compensation for serving as an employee of Evidera.
Charlotte A. Pettersson, MSc Ms. Pettersson has received personal compensation for serving as an employee of PPD Scandinavia AB, part of Thermo Fisher Scientific.
Stephen Wanaski, PhD Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has or had stock in Paragon Biosciences.Dr. Wanaski has or had stock in Emalex Biosciences.
Timothy Cunniff, PharmD Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
David A. Isaacs, MD The institution of Dr. Isaacs has received research support from NIH NINDS. The institution of Dr. Isaacs has received research support from Teva Branded Pharmaceutical Products, R&D, Inc.. The institution of Dr. Isaacs has received research support from Emalex Biosciences, Inc. Dr. Isaacs has received personal compensation in the range of $0-$499 for serving as a attendee at the annual meeting for Center of Excellence Directors with Tourette Association of America. Dr. Isaacs has a non-compensated relationship as a research collaborator with Emalex Biosciences, Inc that is relevant to AAN interests or activities.
Zongqi Xia, MD, PhD The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Genentech/Roche.
Conor Kelly, MD Dr. Kelly has nothing to disclose.
Claire Riley, MD, FAAN Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Emily Song Emily Song has nothing to disclose.
Emma C. Osterhaus Ms. Osterhaus has received research support from University of Pittsburgh School of Medicine.
Wen Zhu, MD Dr. Zhu has nothing to disclose.
Jiyeon Son, MD Ms. Son has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen .
Ahmed Abbas, MD Dr. Abbas has nothing to disclose.
Jaime Toro, MD, FAAN Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Saul Reyes, MD Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Estefania Rojo-Bustamante, MD, PhD Dr. Rojo-Bustamante has nothing to disclose.
Jairo A. Gaitan Alfonso, MD Dr. Gaitan Alfonso has nothing to disclose.
Maria Zafra-Sierra, MD Dr. Zafra-Sierra has nothing to disclose.
Juan P. Rodriguez noriega, MD Dr. Rodriguez noriega has nothing to disclose.
Alexander Vorobyev, MD Dr. Vorobyev has nothing to disclose.
Ghada A. Mohamed, MD Dr. Mohamed has nothing to disclose.
Chirantan Banerjee, MD, MPH Dr. Banerjee has nothing to disclose.
Parneet K. Grewal, MD The institution of Dr. Grewal has received research support from Bristol Myer Squibb Foundation. The institution of Dr. Grewal has received research support from IPSEN Global.
Gina S. Perez-Giraldo, MD Dr. Perez-Giraldo has received personal compensation for serving as an employee of TG therapeutics. Dr. Perez-Giraldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
Sulaiman Abdullah, MD Mr. Abdullah has nothing to disclose.
Aseel A. Alamri Ms. Alamri has nothing to disclose.
Ahmad Assinnari, MBBS, PhD Dr. Assinnari has nothing to disclose.
Salma Bashayreh, MD Dr. Bashayreh has nothing to disclose.
Rula A. AlShimi Ms. AlShimi has nothing to disclose.
Ahmed M. Yassin, MD Dr. Yassin has nothing to disclose.
Khalid El-Salim No disclosure on file
Basheer Khassawneh Basheer Khassawneh has nothing to disclose.
Abdul Jaber Tayem, MD Dr. Tayem has nothing to disclose.
Angel Liu Ms. Liu has nothing to disclose.
Gabriela Zabala No disclosure on file
Sargis Manukyan Mr. Manukyan has nothing to disclose.
Laura M. Locke, NP Ms. Locke has nothing to disclose.
Paula Barreras, MD Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from 好色先生.
Marwa Kaisey, MD Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Kaisey has received research support from NMSS.
Nancy L. Sicotte, MD, FAAN The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
Pascal Sati The institution of Pascal Sati has received research support from National Multiple Sclerosis Society. The institution of Pascal Sati has received research support from National Institutes of Health . The institution of Pascal Sati has received research support from Erwin Rautenberg Fondation. The institution of Pascal Sati has received research support from Department of Defense. Pascal Sati has received intellectual property interests from a discovery or technology relating to health care. Pascal Sati has received publishing royalties from a publication relating to health care.
Omar Al-Louzi, MD The institution of Dr. Al-Louzi has received research support from the National Multiple Sclerosis Society and American Brain Foundation. The institution of Dr. Al-Louzi has received research support from the Department of Defense.
Christopher J. File Mr. File has nothing to disclose.
Anthony Price Mr. Price has nothing to disclose.
Rowaid Ahmad, MBBS Dr. Ahmad has nothing to disclose.
Elena Shanina, MD, FAAN Dr. Shanina has nothing to disclose.
Ruiqing Sun, MD, PhD Dr. Sun has nothing to disclose.
Sarah Stuccio, MD Dr. Stuccio has nothing to disclose.
Matthew Hart, MD Dr. Hart has nothing to disclose.
Amandeep Dolla, MBBS Dr. Dolla has nothing to disclose.
Monica N. Hernandez, PhD Dr. Hernandez has received personal compensation for serving as an employee of BioSpyder Technologies.
Bruce E. Seligmann, PhD Dr. Seligmann has received personal compensation for serving as an employee of BioSpyder Technologies, Inc.. Dr. Seligmann has stock in BioSpyder Technologies, Inc..
Megan A. Opichka, PhD Dr. Opichka has received personal compensation for serving as an employee of BioSpyder Technologies Inc.. Dr. Opichka has received research support from American Heart Association.
Joanne Yeakley, PhD Dr. Yeakley has received personal compensation for serving as an employee of BioSpyder Technologies. Dr. Yeakley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BioSpyder Technologies . Dr. Yeakley has stock in BioSpyder Technologies . Dr. Yeakley has received research support from NIH. Dr. Yeakley has received intellectual property interests from a discovery or technology relating to health care.
Zhoutao Chen, PhD Dr. Chen has received personal compensation for serving as an employee of Biospyder. Dr. Chen has stock in Universal Sequencing.
Gregory Sahagian, MD, FAAN Dr. Sahagian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care.
Salvatore Camiolo, PhD Dr. Camiolo has nothing to disclose.
Dustin Moore Mr. Moore has nothing to disclose.
Neha Prakash, MD The institution of Dr. Prakash has received research support from UCB Biosciences Inc.. The institution of Dr. Prakash has received research support from Parkinson Foundation.
Hyeon Min An, PhD Dr. An has nothing to disclose.
Alice Hsu, PhD Dr. Hsu has nothing to disclose.
Rida F. Ismail, BS Miss Ismail has nothing to disclose.
Kevin Bickart, MD, PhD Dr. Bickart has nothing to disclose.
Muzamil Akhtar, Medical Student Mr. Akhtar has nothing to disclose.
Isra Masood, MBBS Miss Masood has nothing to disclose.
Mohsin Ali, MBBS Dr. Ali has nothing to disclose.
Syed Zaeem Ahmed, MBBS Dr. Ahmed has nothing to disclose.
Fatima Hussain, MBBS Miss Hussain has nothing to disclose.
Ifrah Ansari Miss Ansari has nothing to disclose.
Danish A. Ashraf Mr. Ashraf has nothing to disclose.
Joseph F. McGuire, PhD Dr. McGuire has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Emalex Biosciences.
Richard M. Bittman, PhD Dr. Bittman has received personal compensation for serving as an employee of Bittman Biostat, Inc. Dr. Bittman has stock in Various publically traded corporations.
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Gage Messner Mr. Messner has nothing to disclose.
Karen Truitt, DO Dr. Truitt has stock in QTRX. Dr. Truitt has stock in EXAS. Dr. Truitt has stock in ACAD. Dr. Truitt has stock in ABBV. Dr. Truitt has stock in NVS. Dr. Truitt has stock in VRTX. Dr. Truitt has stock in MRK.
Yoon-Hee Cha, MD, FAAN The institution of Dr. Cha has received research support from Mal de Debarquement Balance Disorders Foundation. Dr. Cha has received research support from University of Minnesota. Dr. Cha has received research support from MNDrive.
Kayla Chan Kayla Chan has nothing to disclose.
Mahmood Gharib Mahmood Gharib has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia Medical .
Joseph Karam Joseph Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Philips. Joseph Karam has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gore.
Emily White, MD Dr. White has nothing to disclose.
Shibani S. Mukerji, MD, PhD Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
Sandra Nelson, MD Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Nelson has received publishing royalties from a publication relating to health care.
William T. Curry, Jr., MD Dr. Curry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RL Datix. Dr. Curry has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for IMRIS. The institution of Dr. Curry has received research support from A shot for life.
April F. Eichler, MD Dr. Eichler has received personal compensation for serving as an employee of Wolters Kluwer Health, UpToDate. An immediate family member of Dr. Eichler has stock in Swan Bio. An immediate family member of Dr. Eichler has received publishing royalties from a publication relating to health care.
Sharon C. Whitney, PA Ms. Whitney has nothing to disclose.
Angela Tang-Tan, BA Ms. Tang-Tan has nothing to disclose.
Sindhu N. Daggupati Miss Daggupati has nothing to disclose.
Christine I. Bent, Medical Student Ms. Bent has nothing to disclose.
Alexandra N. Demetriou Miss Demetriou has nothing to disclose.
Max Thorwald Max Thorwald has nothing to disclose.
William Mack William Mack has received personal compensation for serving as an employee of NFL. William Mack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Imperative Care. The institution of William Mack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanderbilt University (Stryker study) . William Mack has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. William Mack has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goza and Honnald LLC. William Mack has stock in egret therapeutics. William Mack has stock in Borvo. William Mack has stock in Radical Catheters. William Mack has stock in Vastrax. William Mack has stock in Q'Apel. William Mack has stock in Viseon. William Mack has stock in Stream Biomedical. William Mack has stock in Spartan Micro. William Mack has stock in Endostream. The institution of William Mack has received research support from National Institutes of Health.
Christian Pike The institution of Christian Pike has received research support from Estetra SRL. Christian Pike has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH CSR.
Constantinos Sioutas Constantinos Sioutas has nothing to disclose.
Jose Godoy Jose Godoy has nothing to disclose.
Lifu Zhao Lifu Zhao has nothing to disclose.
Selena Chen Selena Chen has nothing to disclose.
Kristina Shkirkova Kristina Shkirkova has nothing to disclose.
Abdallah Khan, MBBS Mr. Khan has nothing to disclose.
Maysoon Azzam, MBBS Miss AZZAM has nothing to disclose.
Malgorzata Miller, MD The institution of Dr. Miller has received research support from NIH StrokeNet VERIFY trial.
Esam Abobaker, DO Dr. Abobaker has nothing to disclose.
Brian Wideman, DO Dr. Wideman has nothing to disclose.
Nadeem I. Khan, MD Dr. Khan has nothing to disclose.
Muhib Khan, MD, FAAN The institution of Dr. Khan has received research support from Mayo Clinic 好色先生 Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Mathew J. Reeves, PhD, BVSc Mathew J. Reeves, PhD, BVSc has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
John Oostema, MD Dr. Oostema has received personal compensation for serving as an employee of Life EMS 好色先生 Centre. Dr. Oostema has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various law firms.
Stephen Ronay, MD Dr. Ronay has nothing to disclose.
John Santucci III, MD Dr. Santucci has nothing to disclose.
Julia M. Agee, MD Dr. Agee has nothing to disclose.
Amrita Mukhopadhyay, MD Dr. Mukhopadhyay has nothing to disclose.
Santiago Martinez Sosa, MBBS Dr. Martinez Sosa has nothing to disclose.
Dorris Luong, NP Ms. Luong has nothing to disclose.
Ning Zhong, MD Dr. Zhong has nothing to disclose.
Hui Li Dr. Li has nothing to disclose.
Hongbo Liu The institution of Hongbo Liu has received research support from China.
Steven J. Roman Troche, MD Dr. Roman Troche has nothing to disclose.
Rafael J. Lopez-Baquero, MD Dr. Lopez-Baquero has nothing to disclose.
Mariam Hull, MD Dr. Hull has received publishing royalties from a publication relating to health care.
Sujal Manohar, MD Dr. Manohar has nothing to disclose.
Jennifer L. Jacobe, Medical Student Miss Jacobe has nothing to disclose.
Rebecca Berger, Medical Student Ms. Berger has nothing to disclose.
Julius B. Anang, MD, FAAN The institution of Dr. Anang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Anang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan.
Gereon Nelles, MD, PhD, FAAN Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Memodio. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industrial. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for German Neurologists Professional Organization. Dr. Nelles has received publishing royalties from a publication relating to health care.
Katrin Schuh Katrin Schuh has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Christian Hentschke, MSc Mr. Hentschke has received personal compensation for serving as an employee of Novartis.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Mathieu Blais Mathieu Blais has nothing to disclose.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Alexandre Vezina, MD Mr. Vezina has nothing to disclose.
Manon Leclerc, PhD Mrs. Leclerc has nothing to disclose.
Vicky Caron Vicky Caron has nothing to disclose.
Karim Makhoul, Sr., MD Dr. Makhoul has nothing to disclose.
Mordechai Z. Smith, MD Dr. Smith has nothing to disclose.
Shital Patel, MD Dr. Patel has nothing to disclose.
Andrew J. Lee, MD Dr. Lee has nothing to disclose.
Ishani Khatiwala, MD Dr. Khatiwala has nothing to disclose.
Mihir Khunte Mr. Khunte has nothing to disclose.
Ajay Malhotra Ajay Malhotra has nothing to disclose.
Huanwen Chen, MD Dr. Chen has nothing to disclose.
Dheeraj Gandhi The institution of Dheeraj Gandhi has received research support from NIH. The institution of Dheeraj Gandhi has received research support from microvention. The institution of Dheeraj Gandhi has received research support from FUS foundation. Dheeraj Gandhi has received intellectual property interests from a discovery or technology relating to health care.
Seong Kyu Yang, MD Dr. Yang has nothing to disclose.
Sarah Hinds Miss Hinds has nothing to disclose.
Huimahn A. Choi, MD The institution of Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma.
Jung Hwa Lee, MD Dr. Lee has nothing to disclose.
William Ondo, MD Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Zachary Grieb, PhD Dr. Grieb has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Ghazal Banisadr, PhD Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Stanley Fisher, MD, FAAN Dr. Fisher has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Thomas Leist, MD, PhD, FAAN Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Sarah A. Morrow, MD, MSC, FRCPC, FAAN Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Ann D. Bass, MD Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Alexion, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. The institution of Dr. Bass has received research support from Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics.
Emily S. Riser, MD Dr. Riser has nothing to disclose.
Jon Riolo, PhD Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Amanpreet Kaur, dds, mph No disclosure on file
James Appio James Appio has received personal compensation for serving as an employee of Bristol Myers Squibb. James Appio has stock in Bristol Myers Squibb.
Massimiliano Cristofanilli, PhD Prof. Cristofanilli has received personal compensation for serving as an employee of Bristol Mayers Squibb . Prof. Cristofanilli has stock in Bristol Mayers Squibb .
Ahmed Z. Obeidat, MD, PhD Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to AAN interests or activities.
Lindsey Vogt, MD Dr. Vogt has nothing to disclose.
Nadia S. Al Azri, OMSB Dr. Al Azri has nothing to disclose.
Carolina Gorodetsky, MD Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic Inc .
George Ibrahim George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synergia. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synergia.
Alfonso Fasano, MD, PhD, FAAN Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Sara Breitbart, NP Ms. Breitbart has nothing to disclose.
Andrea LeBlanc-Millar, NP Mrs. LeBlanc-Millar has nothing to disclose.
Cristina Valencia Sanchez, MD Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities.
Shemonti Hasan, MD Dr. Hasan has nothing to disclose.
Samar Ahmed Amer Samar Ahmed Amer has nothing to disclose.
Misha Khan, MBBS Dr. Khan has nothing to disclose.
Lamis I. Ibrahim, MD Dr. Ibrahim has nothing to disclose.
Hamza Akram, MD Dr. Akram has nothing to disclose.
Mostafa A. Amer Mostafa A. Amer has nothing to disclose.
Walid A. Amin Al-Shroby, MD Dr. Amin Al-Shroby has nothing to disclose.
Khaled Moghib, MBBS Dr. Moghib has nothing to disclose.
Diji Johnson, MBBS Dr. Johnson has nothing to disclose.
Arun R. Antony, MD Dr. Antony has nothing to disclose.
Hira Burhan, MD Dr. Burhan has nothing to disclose.
Rahul Guha, MD Dr. Guha has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Experienced Neurology Consulting.
Rajesh C. Sachdeo, MD Dr. Sachdeo has nothing to disclose.
Alexander Buslov, MD Dr. Buslov has nothing to disclose.
shabbar danish, MD Dr. danish has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic.
Marina Khrizman, DO Dr. Khrizman has received personal compensation for serving as an employee of Hackensack Meridian Health.
Rachel Penn, MD Dr. Penn has nothing to disclose.
Mehdi Belbraouet, MD Dr. Belbraouet has nothing to disclose.
Natalie E. Parks, MD Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Matthew Chedrawe, MD Dr. Chedrawe has nothing to disclose.
Shannon Murphy, MD Dr. Murphy has nothing to disclose.
Meha Prabhu Miss Prabhu has nothing to disclose.
Shreya Tripathy Ms. Tripathy has nothing to disclose.
Anna Marisa Cervantes-Arslanian, MD, FAAN Dr. Cervantes-Arslanian has nothing to disclose.
Steven K. Feske, MD Dr. Feske has received publishing royalties from a publication relating to health care.
Mohamad Abdalkader Mohamad Abdalkader has nothing to disclose.
Pariwat Thaisetthawatkul, MD, FAAN Dr. Thaisetthawatkul has nothing to disclose.
Mark Jedras, DO An immediate family member of Dr. Jedras has stock in Johnson & Johnson.
Peter J. Dyck, MD, FAAN Dr. Dyck has nothing to disclose.
Dean Zeldich, MD Dr. Zeldich has nothing to disclose.
Victor Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Clinton G. Lauritsen, MD Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan.
Claire Ceriani, MD Dr. Ceriani has nothing to disclose.
Cyril David, NP Mr. David has nothing to disclose.
Arjun K. Rangan, MD Dr. Rangan has nothing to disclose.
Hao Ying Hao Ying has nothing to disclose.
Hannah Gardener, ScD Ms. Gardener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intersocietal Accreditation Commission. Ms. Gardener has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ellipse Analytics. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Baum Hedlund. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with A Green Slate Consulting.
Carolina Gutierrez Carolina Gutierrez has nothing to disclose.
Negar Asdaghi, MD Dr. Asdaghi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Tatjana Rundek, MD, PhD The institution of Dr. Rundek has received research support from NIH.
Jose G. Romano, MD, FAAN Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
Gillian L. Gordon-Perue, MD, FAAN The institution of Dr. Gordon-Perue has received research support from CDC Paul Coverdell Grant. The institution of Dr. Gordon-Perue has received research support from Florida Department of Health. Dr. Gordon-Perue has received personal compensation in the range of $500-$4,999 for serving as a Moderator with PRIME ECHO Stroke 好色先生al Webinar.
Camille Barbour, MD Dr. Barbour has nothing to disclose.
Michael J. Lyerly, MD, FAAN Dr. Lyerly has nothing to disclose.
Parin Nanavati, MD Dr. Nanavati has nothing to disclose.
William R. Meador, MD Dr. Meador has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ForensisGroup. The institution of Dr. Meador has received research support from PCORI. The institution of Dr. Meador has received research support from ROCHE/GENENTECH.
Neda Wick Neda Wick has nothing to disclose.
Rati Chkheidze, MD Dr. Chkheidze has nothing to disclose.
Lisa Bianco, DO Dr. Bianco has nothing to disclose.
Michael Sadek Mr. Sadek has nothing to disclose.
Rani A. Sarkis, MD, MSc The institution of Dr. Sarkis has received research support from NINDS.
Alexis M. Hankerson, MPH Miss Hankerson has nothing to disclose.
Page B. Pennell, MD, FAAN The institution of Dr. Pennell has received research support from NIH.
Rebecca E. Amariglio Ms. Amariglio has nothing to disclose.
Janet Orozco, BS Ms. Orozco has nothing to disclose.
Gad Marshall, MD Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma USA Inc. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beth Israel Deaconness Medical Center. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publications.
Maria Andreina Hernandez, MD Dr. Hernandez has nothing to disclose.
Vanessa Ocon Miss Ocon has nothing to disclose.
Venkata Pravallika Putrevu, MBBS Dr. Putrevu has nothing to disclose.
Erin M. Feinstein, DO Dr. Feinstein has nothing to disclose.
Mario R. Cornejo Olivas, MD Dr. Cornejo Olivas has received research support from UNIVERSIDAD CIENTIFICA DEL SUR. The institution of Dr. Cornejo Olivas has received research support from CHDI. The institution of Dr. Cornejo Olivas has received research support from NIH. The institution of Dr. Cornejo Olivas has received research support from GP2/ASAP/MJFF. Dr. Cornejo Olivas has a non-compensated relationship as a Secretary elect with MDS-PAS that is relevant to AAN interests or activities.
Maryenela Z. Illanes-Manrique, MD, Atlantic Fellow The institution of Dr. Illanes-Manrique has received research support from GLOBAL BRAIN HEALTH INSTITUTE.
Larry Adams No disclosure on file
Sheila C. Suarez, MD Dr. Suarez has nothing to disclose.
Julia E. Rios Pinto, Neuropsicóloga Dr. Rios Pinto has nothing to disclose.
Pedro Mena Pedro Mena has nothing to disclose.
Farid Rajabli, PhD Farid Rajabli has nothing to disclose.
Katalina McInerney Katalina McInerney has nothing to disclose.
Ivan Cornejo-Herrera, MD Dr. Cornejo-Herrera has nothing to disclose.
Michael L. Cuccaro No disclosure on file
Jeffery Vance, MD, PhD Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Koni Mejia Dr. Mejia has nothing to disclose.
Edward Ochoa-Valle Edward Ochoa-Valle has nothing to disclose.
Angel Medina-Colque No disclosure on file
Serggio Lanata, MD Dr. Lanata has nothing to disclose.
Azizi Seixas No disclosure on file
Pilar Davila, Bachelor of Public Health Miss Davila has nothing to disclose.
Midiam Silva-Bullon No disclosure on file
Elison Sarapura-Castro, MD Dr. Sarapura-Castro has nothing to disclose.
Carrie M. Hersh, DO, MSc, FAAN Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Yolanda Aladro Yolanda Aladro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Almirall, Sanofi, Novartis, Bristoll. The institution of Yolanda Aladro has received research support from Roche, Almirall, Merck.
James B. Lewin, PharmD Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Changyu Shen, PhD Dr. Shen has received personal compensation for serving as an employee of Biogen. Dr. Shen has stock in Biogen.
Ivan Bozin Dr. Bozin has received personal compensation for serving as an employee of Biogen. Dr. Bozin has received personal compensation for serving as an employee of Arvelle Therapeutics. Dr. Bozin has stock in Biogen.
Zhaonan Sun, PhD Dr. Sun has received personal compensation for serving as an employee of Biogen. Dr. Sun has stock in Biogen.
Kaitlyn Stoehr, MS5 Ms. Stoehr has nothing to disclose.
Sithmi M. Jayasundara Miss Jayasundara has nothing to disclose.
Rafael Maarek Mr. Maarek has received research support from National Heart Lung & Blood Institute. Mr. Maarek has received research support from Richard K. Gershon Endowed Medical Student Research Fellowship.
David J. Vargas Estrella Mr. Vargas Estrella has nothing to disclose.
Rachel S. Choi Ms. Choi has nothing to disclose.
Amedeo Rapuano Amedeo Rapuano has nothing to disclose.
Andrew B. Koo, MD Dr. Koo has nothing to disclose.
Yilun Chen Ms. Chen has nothing to disclose.
Jessica Magid-Bernstein, MD, PhD Dr. Magid-Bernstein has nothing to disclose.
Lena O'Keefe, MD Dr. O'Keefe has nothing to disclose.
Ryan Hebert Ryan Hebert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus .
Farhad Bahrassa Farhad Bahrassa has nothing to disclose.
M. B. Westover, MD, PhD Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Charles Matouk Charles Matouk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Silk Road Medical. Charles Matouk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Charles Matouk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navigantis.
Nils Petersen, MD The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH.
Emily J. Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Jennifer A. Kim, MD Dr. Kim has nothing to disclose.
Shiv K. Jha, MBBS Dr. Jha has nothing to disclose.
Monika Pandit, MBBS Dr. Pandit has nothing to disclose.
Eric Mariuma, MD Dr. Mariuma has nothing to disclose.
Binod Mehta, MD Dr. Mehta has nothing to disclose.
Jeremy Wong, MD Dr. Wong has nothing to disclose.
Nanthaya Tisavipat, MD Miss Tisavipat has nothing to disclose.
Natthapon Rattanathamsakul, MD Dr. Rattanathamsakul has nothing to disclose.
Mary Lang Ms. Lang has received intellectual property interests from a discovery or technology relating to health care.
Grant Welk, BS Mr. Welk has nothing to disclose.
Deena Tajfirouz, MD Dr. Tajfirouz has nothing to disclose.
Kevin Chodnicki Kevin Chodnicki has nothing to disclose.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
John Chen John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Arlinda Deng, MD Dr. Deng has nothing to disclose.
Bogdana Petko, MD Dr. Petko has nothing to disclose.
William A. Dalrymple, MD Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REACH. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for M3. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Boxer Capital. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Capvision. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Cencora. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Lumanity. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Huntington Study Group. The institution of Dr. Dalrymple has received research support from Huntington's Disease Society of America.
Alaina Giacobbe, MD Dr. Giacobbe has nothing to disclose.
Yuyao Sun, MD Dr. Sun has nothing to disclose.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Yohei Harada, MD Dr. Harada has nothing to disclose.
Maria G. Cardona-Gonzalez, MD Dr. Cardona-Gonzalez has nothing to disclose.
Daniel J. Burdick, MD, FAAN Dr. Burdick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis Precision Medicines. The institution of Dr. Burdick has received research support from AbbVie. The institution of Dr. Burdick has received research support from Athira. The institution of Dr. Burdick has received research support from Cerevel. The institution of Dr. Burdick has received research support from Merck. The institution of Dr. Burdick has received research support from Neuraly. The institution of Dr. Burdick has received research support from Pharma 2B. The institution of Dr. Burdick has received research support from Jazz Pharmaceuticals. The institution of Dr. Burdick has received research support from Praxis. The institution of Dr. Burdick has received research support from Sage Therapeutics. The institution of Dr. Burdick has received research support from Biogen. The institution of Dr. Burdick has received research support from Cerevance. The institution of Dr. Burdick has received research support from UCB.
Alen Delic Alen Delic has nothing to disclose.
Raymond D. Park, MD Dr. Park has nothing to disclose.
Pinky H. Agarwal, MD, FAAN Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Abhiram Parameswaran, MBBS Dr. Parameswaran has nothing to disclose.
Abhigyan Datta, MD Dr. Datta has nothing to disclose.
Praveen Hariharan, MD Dr. Hariharan has nothing to disclose.
Deanna Teoh, MD Dr. Teoh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Asieris. The institution of Dr. Teoh has received research support from US Department of Defense. The institution of Dr. Teoh has received research support from Moderna. The institution of Dr. Teoh has received research support from Jounce Therapeutics. The institution of Dr. Teoh has received research support from GSK.
Katherine Cooke, MD Dr. Cooke has nothing to disclose.
Markus D. Schirmer, PhD The institution of Dr. Schirmer has received research support from National Institute of Aging.
Erik Lindgren, MD, PhD The institution of Dr. Lindgren has received research support from The Swedish Research Council. Dr. Lindgren has received research support from The Swedish Heart and Lung Foundation.
Luca Angeleri, BS Mr. Angeleri has nothing to disclose.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Natalia S. Rost, MD, MPH, FAAN, FAHA Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Yue Wang, MD Dr. Wang has nothing to disclose.
Christine Smith The institution of Dr. Smith has received research support from B.J. and Eve Wilder Excellence in Epilepsy Research Fund. The institution of Dr. Smith has received research support from National Institutes of Health. Dr. Smith has received personal compensation in the range of $100,000-$499,999 for serving as a Staff Physician with Department of Veterans Affairs.
Subeikshanan Venkatesan, MBBS Dr. Venkatesan has nothing to disclose.
John K. Whalen, DO Dr. Whalen has nothing to disclose.
Christina Massrey, MD Dr. Massrey has nothing to disclose.
Abhijit R. Das, MD Dr. Das has nothing to disclose.
Ameya S. Walimbe, MD, PhD Dr. Walimbe has nothing to disclose.
Brooke Evans, MD Dr. Evans has nothing to disclose.
Jamie Solis, MD Dr. Solis has nothing to disclose.
Whitney Franklin, MD, PhD Dr. Franklin has nothing to disclose.
Kristen Fisher, DO Dr. Fisher has nothing to disclose.
Sreenivas Avula, MD Dr. Avula has nothing to disclose.
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Joanne Crandall Ms. Crandall has nothing to disclose.
Kaitlin A. Greene, MD Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Headache Society. An immediate family member of Dr. Greene has or had stock in Auxetics. The institution of Dr. Greene has received research support from Eli-Lilly. The institution of Dr. Greene has received research support from Upsher-Smith. The institution of Dr. Greene has received research support from Amgen.
Lauren Shin, MD Dr. Shin has nothing to disclose.
Amy Gelfand, MD An immediate family member of Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Headache Society. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of an immediate family member of Dr. Gelfand has received research support from Hoffman LaRoche. The institution of an immediate family member of Dr. Gelfand has received research support from Vigil Neuroscience. The institution of an immediate family member of Dr. Gelfand has received research support from NIH/NINDS. The institution of Dr. Gelfand has received research support from PCORI. The institution of Dr. Gelfand has received research support from UCSF RAP grant. Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Weill Cornell Neurology Department. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Taiwan Headache Society. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Author with Elsevier. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with College Board SSD. Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Speaker with Kobenhavns Unversitet. An immediate family member of Dr. Gelfand has a non-compensated relationship as a Clinical Trial Steering Committee Member with Roche/Genentech that is relevant to AAN interests or activities.
Jessica Hemm Mrs. Hemm has received personal compensation for serving as an employee of Rush Medical Center.
Wdasie Ayele, student Ms. Ayele has nothing to disclose.
Sarah M. Chen, LCSW Ms. Chen has nothing to disclose.
Evelyn Stevens, MPH Miss Stevens has received personal compensation for serving as an employee of Parkinson's Foundation.
Jori Fleisher, MD, MSCE, FAAN The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Elizabeth C. Rachchh Mrs. Rachchh has received personal compensation for serving as an employee of Lewy Body Dementia Association.
Keith N. Fargo, PhD An immediate family member of Dr. Fargo has received personal compensation for serving as an employee of Parexel. Dr. Fargo has received personal compensation for serving as an employee of Lewy Body Dementia Association. Dr. Fargo has received personal compensation for serving as an employee of CMT Research Foundation.
Diane Mariani, LCSW Ms. Mariani has nothing to disclose.
Angela Taylor Mrs. Taylor has received personal compensation for serving as an employee of Lewy Body Dementia Association.
Sandhya Seshadri, PhD The institution of Dr. Seshadri has received research support from NIH.
Cintra Bentley, Esq Ms. Bentley has received personal compensation in the range of $5,000-$9,999 for serving as a Member of LBD Advisory Panel with Rush University Medical Center.
Thomas J. Manak Mr. Manak has received personal compensation in the range of $0-$499 for serving as a Advisory Board Member with NIH.
Allegra Miller, volunteer Ms. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Caregiver Advisory Panel for Persevere with NIH.
Claire E. Pensyl, MA, JD Ms. Pensyl has nothing to disclose.
Carmen Pierce Mrs. Pierce has received personal compensation in the range of $0-$499 for serving as a Advisory Member with NIH.
Margaret Voss, Co author Ms. Voss has received personal compensation in the range of $5,000-$9,999 for serving as a LBD ADVISORY PANEL MEMBER with RUSH UNIVERSITY MEDICAL CENTER.
Bichun Ouyang Bichum Ouyang has nothing to disclose.
Joshua Chodosh, MD The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NINR.
Jorge Beovides Vazquez, DO Dr. Beovides Vazquez has nothing to disclose.
Ricardo Ramos, MD Dr. Ramos has nothing to disclose.
Anita Arias, NP Miss Arias has nothing to disclose.
Sadia Waheed, MBBS Dr. Waheed has nothing to disclose.
Fawad Yousuf, MBBS Dr. Yousuf has nothing to disclose.
Fahim Barmak, MD Dr. Barmak has nothing to disclose.
Jamil Numan, MD Dr. Numan has nothing to disclose.
Stephanie Syc-Mazurek, MD, PhD Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Laura Cacciaguerra, MD, PhD Dr. Cacciaguerra has nothing to disclose.
Paul Farnsworth, DO Dr. Farnsworth has nothing to disclose.
M. Tariq Bhatti, MD Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Receptos . Dr. Bhatti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH LHON gene therapy study .
Jan-Mendelt Tillema, MD Dr. Tillema has nothing to disclose.
Varun K. Singh, MD, MBBS Dr. Singh has nothing to disclose.
Sanchit S. Chouksey, MD, MBBS Dr. Chouksey has nothing to disclose.
Rameshwar N. Chaurasia, MD, DM, FRCP (Edin), FAMS Dr. Chaurasia has nothing to disclose.
Abhishek Pathak, MD, MBBS, DM Dr. Pathak has nothing to disclose.
Anand Kumar, MD, DM Dr. Kumar has nothing to disclose.
Deepika Joshi, MD Dr. Joshi has nothing to disclose.
Vijaya Mishra, MD, MBBS, DM Prof. Mishra has nothing to disclose.
Pratishtha Sengar No disclosure on file
Filip Bergquist The institution of Filip Bergquist has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Filip Bergquist has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Arvid Carlsson Research AB. The institution of Filip Bergquist has received research support from Swedish Government. The institution of Filip Bergquist has received research support from Parkinsonfonden. The institution of Filip Bergquist has received research support from Neuro Sweden. The institution of Filip Bergquist has received research support from Swedish Research Council. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has a non-compensated relationship as a Advisor with Sense4Care that is relevant to AAN interests or activities.
Jason L. Aldred, MD, FAAN Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $0-$499 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from NeuroDerm. The institution of Dr. Aldred has received research support from PhotoPharma. The institution of Dr. Aldred has received research support from Lilly.
Erik H. Danielsen, MD, PhD Dr. Danielsen has nothing to disclose.
Camille Carroll, MD The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Global Kinetic. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scient. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. The institution of Dr. Carroll has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medscape. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Carroll has received research support from Parkinson's UK. The institution of Dr. Carroll has received research support from Edmond J Safra Foundation. The institution of Dr. Carroll has received research support from Cure Parkinson's. The institution of Dr. Carroll has received research support from Parkinson's UK. The institution of Dr. Carroll has received research support from NHSX.
Amy M. Spiegel, PhD Amy Spiegel has received personal compensation for serving as an employee of AbbVie. Amy Spiegel has received stock or an ownership interest from AbbVie.
Cheney Matthews No disclosure on file
Jia Jia, PhD Mr. Jia has received personal compensation for serving as an employee of Abbvie.
Victor Fung, MD, MBBS, PhD Dr. Fung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fung has received publishing royalties from a publication relating to health care.
Megha Shah Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Edward Fox, MD, PhD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Peiqing Qian, MD Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. The institution of Dr. Robertson has received research support from UCB Biosciences. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Deren Huang, MD Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Koby Mok, PhD Dr. Mok has received personal compensation for serving as an employee of TG Therapeutics. Dr. Mok has received stock or an ownership interest from TG Therapeutics.
Yanzhi Hsu, PhD Dr. Hsu has received personal compensation for serving as an employee of TG Therapeutics Inc. Dr. Hsu has stock in TG Therapeutics Inc.
Yihuan Xu Yihuan Xu has received personal compensation for serving as an employee of TG Therapeutics.
Chris Rowland Chris Rowland has received personal compensation for serving as an employee of TG Therapeutics. Chris Rowland has stock in TG Therapeutics.
Karthik Bodhinathan, PhD Dr. Bodhinathan has received personal compensation for serving as an employee of TG Therapeutics. Dr. Bodhinathan has stock in TG Therapeutics.
Peter Sportelli, BS Mr. Sportelli has received personal compensation for serving as an employee of TG Therapeutics. Mr. Sportelli has stock in TG Therapeutics, Inc.
Jackie Parker, MPH Ms. Parker has received personal compensation for serving as an employee of TG Therapeutics. Ms. Parker has stock in TG Therapeutics.
Hari Miskin Hari Miskin has received personal compensation for serving as an employee of TG Therapeutics, Inc.. Hari Miskin has stock in TG Therapeutics, Inc..
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Wilmer Hale Cutler Pickering. Dr. Steinman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Shane Musick, MD Dr. Musick has nothing to disclose.
Shalane A. Morales-Nunez, MD Dr. Morales-Nunez has nothing to disclose.
Nilufer Yalcin, MD Dr. Yalcin has nothing to disclose.
Manan Shah, MD, MBBS Dr. Shah has nothing to disclose.
Matthew Lee, MD Dr. Lee has nothing to disclose.
Klepper Alfredo Garcia, MD Dr. Garcia has nothing to disclose.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Isaac Smith, DO, MS Dr. Smith has nothing to disclose.
Eduard H. Valdes, MD Dr. Valdes has received research support from a T32 NIH Grant.
Allison Muha, MD Dr. Muha has nothing to disclose.
Ekaterina Bakradze, MD Dr. Bakradze has nothing to disclose.
Kristen Sandefer, MD Dr. Sandefer has nothing to disclose.
Jori E. May, MD Dr. May has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Anticoagulation Forum. Dr. May has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for JEM Consulting, LLC.
Laura Gilbert, DO, MBA Dr. Gilbert has nothing to disclose.
Emma J. Lott Ms. Lott has nothing to disclose.
Susie Kim Ms. Kim has nothing to disclose.
Alyssa Rust, MD Miss Rust has nothing to disclose.
Amy McQueen, PhD Dr. McQueen has nothing to disclose.
Bhooma R. Aravamuthan, MD, DPhil, FCNS, FAAN The institution of Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Aravamuthan has received research support from Child Neurology Foundation. The institution of Dr. Aravamuthan has received research support from American Board of Psychiatry and Neurology. The institution of Dr. Aravamuthan has received research support from Centers for Disease Control. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Kazuo Fujihara, MD Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Mirla L. Avila, MD, FAAN Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Yanping Wu, MD Ms. Wu has received personal compensation for serving as an employee of Amgen. Ms. Wu has stock in Amgen.
Kristina R. Patterson, MD, PhD Dr. Patterson has received personal compensation for serving as an employee of Amgen. Dr. Patterson has stock in Amgen.
Daniel M. Cimbora, PhD Dr. Cimbora has received personal compensation for serving as an employee of Amgen. Dr. Cimbora has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. Cimbora has received personal compensation for serving as an employee of Viela Bio. Dr. Cimbora has stock in Amgen.
Yixin Zhan Mr. Zhan has nothing to disclose.
Shijia Chen, Master of Clinical Medicine Miss Chen has nothing to disclose.
Zhenghan Jin, Medical Undergraduate Mr. Jin has nothing to disclose.
Jiping Zhou, MD, MPH Dr. Zhou has nothing to disclose.
Yin-Xi Zhang, MD Dr. Zhang has received research support from the Natural Science Foundation of Zhejiang Province (LQ23H090011).
Qun Hou No disclosure on file
Yi Wang No disclosure on file
Guoqing Zheng, MD, PhD Dr. Zheng has nothing to disclose.
Yang Zheng, MD, PhD Dr. Zheng has nothing to disclose.
Shayak Sen, MD Dr. Sen has nothing to disclose.
Ishan Kanungo, MD Dr. Kanungo has nothing to disclose.
Alex C. Aw, MD Mr. AW has nothing to disclose.
Duaa Jabari, MD Dr. Jabari has nothing to disclose.
Magdalena Lana Miss Lana has nothing to disclose.
Sarah Anderson Miss Anderson has nothing to disclose.
Gary Gong, MD, PhD Dr. Gong has nothing to disclose.
Diana Wang Ms. Wang has nothing to disclose.
Ali Mahta, MD Dr. Mahta has received research support from Brown University Health.
Ariyaporn Haripottawekul Miss Haripottawekul has nothing to disclose.
Christopher Chang, BS Mr. Chang has nothing to disclose.
Kevin V. Nguyen Mr. Nguyen has nothing to disclose.
Michelle L. Payne, PharmD Dr. Payne has nothing to disclose.
Dylan Wolman, MD Dr. Wolman has nothing to disclose.
Joseph Namkung Mr. Namkung has nothing to disclose.
Brenton T. Bicknell, BS Mr. Bicknell has nothing to disclose.
Roger Smalligan, MD Dr. Smalligan has nothing to disclose.
Chandler E. Davis, MBBS Mr. Davis has nothing to disclose.
Kimberly Chieh Miss Chieh has nothing to disclose.
Amit Arora, MD Dr. Arora has a non-compensated relationship as a Board Member with Alabama Academy of Neurology that is relevant to AAN interests or activities.
Rongze Wang, MD Dr. Wang has nothing to disclose.
Jintai Yu No disclosure on file
Harini Sarva, MD, FAAN Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Michele Tagliati, MD, FAAN Dr. Tagliati has received publishing royalties from a publication relating to health care.
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Fabrizio Stocchi Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Tamar Yardeni Tamar Yardeni has received personal compensation for serving as an employee of Neuroderm.
Nelson F. Lopes Dr. Lopes has received personal compensation for serving as an employee of Neuroderm.
Jonathan Pereira, MD Mr. Pereira has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Warda A. Alrubasy, MBBS Dr. Alrubasy has nothing to disclose.
Shams K. Sameer, MBBS Ms. Sameer has nothing to disclose.
Fatema A. Alhnidi, MD Dr. Alhnidi has nothing to disclose.
Husam N. Abu Daoud, MBBS Dr. Abu Daoud has nothing to disclose.
Hamidullah Sahibzada Mr. Sahibzada has nothing to disclose.
mohamed w. salim, Sr., MD, MBBS Dr. salim has nothing to disclose.
Hend Abo Helow, MBBS Dr. Abo Helow has nothing to disclose.
‪Ekram H. Hasanin‬‏ Miss Hasanin?? has nothing to disclose.
Kashmaila Ali Miss Ali has nothing to disclose.
Aavaisra Ali Miss Ali has nothing to disclose.
Aparna Manoj Miss Manoj has nothing to disclose.
Elizabeth H. Morrison-Banks No disclosure on file
Maurizio Grassano, MD Dr. Grassano has received research support from American Brain Foundation, ALS Association and 好色先生.
Francesca Palumbo Dr. Palumbo has nothing to disclose.
Barbara Iazzolino Barbara Iazzolino has nothing to disclose.
Cristina Moglia Cristina Moglia has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Swanny Shi Swanny Shi has nothing to disclose.
Rishi Gupta, MD Dr. Gupta has nothing to disclose.
Ammar I. Hamza, MD Mr. Hamza has nothing to disclose.
Ahmad Aljbaly Mr. Aljbaly has nothing to disclose.
Hasan Awad Mr. Awad has nothing to disclose.
Kefah A. Al-Hayk, MD Dr. Al-Hayk has nothing to disclose.
Alisha Qaiser, MD Dr. Qaiser has nothing to disclose.
Daniela Lozano, MD Dr. Lozano has nothing to disclose.
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
Christopher M. Goshgarian, MD Dr. Goshgarian has nothing to disclose.
Zheng Lan, MD, PhD Dr. Lan has nothing to disclose.
Ibrahim Migdady, MD Dr. Migdady has nothing to disclose.
Namal Seneviratne, MD Mr. Seneviratne has nothing to disclose.
Eun Hye Kim, MD Dr. Lee has stock in Pacific biosciences.
Hira Chaudhary, MD Dr. Chaudhary has nothing to disclose.
Vanesa K. Vanderhye, RN Mrs. Vanderhye has nothing to disclose.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Oana M. Dumitrascu, MD, FAAN Dr. Dumitrascu has nothing to disclose.
Andrej Urumov, MD Mr. Urumov has nothing to disclose.
Carrie Milliard Carrie Milliard has received personal compensation for serving as an employee of FTD Disorders Registry, LCC. The institution of Carrie Milliard has received research support from NIH - PTE Mayo Clinic .
Penny Dacks, PhD Penny Dacks has received personal compensation for serving as an employee of The Association for Frontotemporal Degeneration.
Sweatha Reddy Ms. Reddy has nothing to disclose.
Mary Krause Miss Krause has received personal compensation for serving as an employee of FTD Disorders Registry. Miss Krause has received personal compensation for serving as an employee of Crossroads Hospice & Palliative Care.
Lakecia Vincent, RN Mrs. Vincent has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD Dr. Al-Sabbagh has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD Dr. Eswaradass has nothing to disclose.
Arpan Patel, MBBS Dr. Patel has nothing to disclose.
Aliya Rashid, DO Dr. Rashid has nothing to disclose.
Shayan Marsia, MBBS Dr. Marsia has nothing to disclose.
Zainab Siddiqua Ibrahim, MBBS Dr. Ibrahim has nothing to disclose.
Ruqiat M. Batool Ms. Batool has nothing to disclose.
Rameez A. Merchant, MBBS Dr. Merchant has nothing to disclose.
Sayed Mustafa M. Shah, MBBS Dr. Shah has nothing to disclose.
Cemal Karakas, MD Dr. Karakas has nothing to disclose.
Anabel Puri Ms. Puri has nothing to disclose.
Dylan C. Brock, MD Dr. Brock has nothing to disclose.
Sean B. Woods, MD Mr. Woods has nothing to disclose.
Alan Li, MD Dr. Li has nothing to disclose.
Mohammad Khasawneh, MD Dr. Khasawneh has nothing to disclose.
Nathaniel Stacy, MD Dr. Stacy has nothing to disclose.
Alexander Shtilbans, MD, PhD, FAAN Dr. Shtilbans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Shtilbans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals. The institution of Dr. Shtilbans has received research support from NIH. The institution of Dr. Shtilbans has received research support from Praxis Precision Medicines.
Carly Skudin Ms. Skudin has nothing to disclose.
Alexandra G. Roberts, MS Ms. Roberts has nothing to disclose.
QIhao Zhang Dr. Zhang has nothing to disclose.
Tanner Crews, BA Mr. Crews has nothing to disclose.
Kelly Gillen, PhD Prof. Gillen has received personal compensation in the range of $500-$4,999 for serving as a Grant editor with SUNY Buffalo.
Eileen Chang Ms. Chang has nothing to disclose.
Yi Wang, PhD Prof. Wang has received intellectual property interests from a discovery or technology relating to health care.
Alexey V. Dimov, PhD Dr. Dimov has nothing to disclose.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Douglas K. Sato, MD Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck.
Jodie Burton, MD, FAAN Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a 好色先生al Chair with EMD Serono that is relevant to AAN interests or activities.
Michael A. Smith No disclosure on file
William Rees William Rees has received personal compensation for serving as an employee of Horizon Therapeutics. William Rees has received personal compensation for serving as an employee of Viela Bio. William Rees has received stock or an ownership interest from Horizon Therapeutics. William Rees has received stock or an ownership interest from Viela Bio. William Rees has received intellectual property interests from a discovery or technology relating to health care. William Rees has received intellectual property interests from a discovery or technology relating to health care.
Kaitlyn Palmer, MD Dr. Palmer has nothing to disclose.
Devon Conway, MD Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Mengke Du Mengke Du has nothing to disclose.
Albert Aboseif, DO Dr. Aboseif has received research support from the Eugene & Marcia Applebaum Fellowship Grant.
Carol Swetlik, MD An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Julie Widmar, NP Ms. Widmar has received personal compensation for serving as an employee of Amgen .
Amy Kunchok, MBBS Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal .
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Julia O'Mahony Ms. O'Mahony has nothing to disclose.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Catherine G. Shang, MD Ms. shang has nothing to disclose.
Minghua Liu Minghua Liu has nothing to disclose.
Noora C. Haghighi, MS Miss Haghighi has nothing to disclose.
Elida Romo, BS Miss Romo has nothing to disclose.
Samantha Jankowski No disclosure on file
Raeann Bourscheid, MD Dr. Bourscheid has nothing to disclose.
Whitney A. Booker, MD Dr. Booker has nothing to disclose.
Alison Seitz, MD Dr. Seitz has stock in Colgate Palmolive.
Sara Shapouran, MD Dr. Shapouran has nothing to disclose.
Lauren Mamer No disclosure on file
William J. Meurer, MD Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Berry Consultants. The institution of Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meurer Consulting. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Emergency Medicine. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Trials Journal . Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Academic Emergency Medicine Journal. Dr. Meurer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Meurer Consulting. The institution of Dr. Meurer has received research support from NIH and AHRQ. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of Grants and FDA submissions with NIH and FDA. Dr. Meurer has a non-compensated relationship as a Member of Board of Directors with Society for Clinical Trials that is relevant to AAN interests or activities.
Ava L. Liberman, MD Dr. Liberman has nothing to disclose.
Liam Shields, MD Dr. Shields has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American College of Obstetricians & Gynecologists. The institution of Dr. Shields has received research support from AHRQ. Dr. Shields has received intellectual property interests from a discovery or technology relating to health care. Dr. Shields has received publishing royalties from a publication relating to health care.
Jane L. Holl, MD The institution of Dr. Holl has received research support from NIH.
Eliza C. Miller, MD Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Matthew C. Loftspring, MD, PhD Dr. Loftspring has nothing to disclose.
Brian Chong, MD Dr. Chong has stock in Rapid AI.
Kari Scaletta, NP Mrs. Scaletta has nothing to disclose.
Mahmoud A. Marouf, MD Dr. Marouf has nothing to disclose.
Bassel E. Alrabadi, MD Dr. Alrabadi has nothing to disclose.
Natalie Bandak, MD Miss Bandak has nothing to disclose.
Zaid I. Badran, MD Mr. Badran has nothing to disclose.
Sohail F. Batarseh Mr. Batarseh has nothing to disclose.
Haitham O. Alhazaimeh Mr. Alhazaimeh has nothing to disclose.
Jai G. Shahani, MD Mr. Shahani has nothing to disclose.
Roopa Sharma, MD Dr. Sharma has nothing to disclose.
Nancy Song, MD Dr. Song has nothing to disclose.
Zainab Zahra, MD Dr. Zahra has nothing to disclose.
Ahsan Ali, MD Dr. Ali has nothing to disclose.
Vieh M. Kung, MD Dr. Kung has nothing to disclose.
Chetna Dengri, MD Dr. Dengri has a non-compensated relationship as a Trainee board member with Neurology 好色先生 Journal Editorial Board that is relevant to AAN interests or activities.
Saira Afzal, MD Dr. Afzal has nothing to disclose.
Efrain D. Salgado, MD Dr. Salgado has nothing to disclose.
Mubashir Pervez, MD, MBBS, FAAN Dr. Pervez has nothing to disclose.
Haris Iqbal Mr. Iqbal has nothing to disclose.
Ali Tanvir Dr. Tanvir has nothing to disclose.
Ahmad Nawaz, Jr., MBBS Dr. Nawaz has nothing to disclose.
Muhammad A. Khawaja, MBBS Dr. Khawaja has nothing to disclose.
Grace Mausisa, RN, NP Ms. Mausisa has received personal compensation for serving as an employee of Alector. Ms. Mausisa has stock in Alector. An immediate family member of Ms. Mausisa has stock in Roche.
Devon Chenette, PhD Dr. Chenette has received personal compensation for serving as an employee of Alector. Dr. Chenette has stock in Alector.
Annick de Bruin Ms. de Bruin has received personal compensation for serving as an employee of CISCRP.
Susan Gorky, Other Ms. Gorky has received personal compensation for serving as an employee of Let's Win Pancreatic Cancr . Ms. Gorky has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Alector. Ms. Gorky has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Policy vs. Politics . Ms. Gorky has stock in BMS. Ms. Gorky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Let's Win Pancreatic Cancer .
Tiffany W. Chow, MD, FAAN Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA.
Sabrina Leung Ms. Leung has received research support from American Society of Colon and Rectal Surgeons.
Olivia C. Iverson, BA, BM Ms. Iverson has nothing to disclose.
Laine Green, MD Dr. Green has nothing to disclose.
Masahiro Nomoto, MD Prof. Nomoto has nothing to disclose.
Hayato Yabe, MD, PhD Dr. Yabe has nothing to disclose.
Rina Ando, MD Dr. Ando has nothing to disclose.
Yasuhiro Sumiyoshi Mr. Sumiyoshi has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan. Mr. Sumiyoshi has received personal compensation for serving as an employee of SNLD, Ltd., Japan.
Takami Akagi, PhD Dr. Akagi has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Dr. Akagi has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.
Ryota Ise, PhD Dr. Ise has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Dr. Ise has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.
Chizu Date Ms. Date has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Ms. Date has received personal compensation for serving as an employee of Shin NIppon Biomedical Laboratories, Ltd., Japan.
Yuki Akiyoshi, PhD Dr. Akiyoshi has received personal compensation for serving as an employee of SNBL, Ltd.. Dr. Akiyoshi has received personal compensation for serving as an employee of Tour de Medication, Ltd.. Dr. Akiyoshi has stock in SNBL, Ltd..
Satoshi Nakano Mr. Nakano has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Mr. Nakano has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.
Ryosuke Suzuki Mr. Suzuki has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Mr. Suzuki has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Tamara Miller, MD Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics Therapeutics, Abbvie, Genentech. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono, TG Therapeutics, Biogen, Abbvie, Genentech, Lundbeck. The institution of Dr. Miller has received research support from Abbvie, Ipsen, Alexion, Pfizer, BMS, Genentech, ThermoFisher Scientific.
Gabriel Pardo, MD, FAAN Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen . Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Pardo has or had stock in Progentec Diagnostics.Dr. Pardo has or had stock in Cadenza Bio.
Martin I. Belkin, DO Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD serono. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Belkin has received stock or an ownership interest from Biogen.
Jonathan C. Calkwood, MD Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bio. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Calkwood has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Calkwood has received research support from Sanofi. The institution of Dr. Calkwood has received research support from Novartis. The institution of Dr. Calkwood has received research support from Astra Zenica. The institution of Dr. Calkwood has received research support from TG Therapeutics. Dr. Calkwood has a non-compensated relationship as a Board of Trustees with National MS Society that is relevant to AAN interests or activities.
Salvatore Napoli, MD Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for vaccine injury.
Christopher C. LaGanke, MD Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GSK. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono EMD. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Theodore R. Brown, MD Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck.
Craig E. Herrman, MD The institution of Dr. Herrman has received research support from Genentech. The institution of Dr. Herrman has received research support from Merck . The institution of Dr. Herrman has received research support from Novartis.
John Scagnelli, MD The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Scagnelli has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Scagnelli has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for NC Neurologic Society.
April A. Erwin, MD Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Erwin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Dr. Erwin has received research support from Genentech. The institution of Dr. Erwin has received research support from Abbvie. The institution of Dr. Erwin has received research support from Novartis. The institution of Dr. Erwin has received research support from Biogen.
Barry A. Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Chris Garner Chris Garner has received personal compensation for serving as an employee of TG Therapeutics Inc.. Chris Garner has stock in TG Therapeutics, Inc..
Christopher D. Lee, MD Dr. Lee has nothing to disclose.
Eufrosina I. Young, MD The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Lindsay Ross, MD Dr. Ross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapuetics. Dr. Ross has received publishing royalties from a publication relating to health care.
Marisa P. McGinley, DO Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Daniel Ontaneda, MD, PhD, FAAN Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Kunio Nakamura, PhD Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Katherine Havard-Coiro, MD Dr. Havard-Coiro has nothing to disclose.
Madeha Khwaja, MD Dr. Khwaja has nothing to disclose.
Eric Goldstein, MD Dr. Goldstein has nothing to disclose.
Marissa Kellogg, MD, MPH, FAAN The institution of Dr. Kellogg has received research support from VA & DoD.
David C. Spencer, MD, FAAN Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuiticals. Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Spencer has received research support from NIH. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative 好色先生 Concepts.
Katherine Park, MD Dr. Park has nothing to disclose.
Matthew McCaskill, DO Dr. McCaskill has nothing to disclose.
Lia D. Ernst, MD Dr. Ernst has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz.
Kathryn Matthews, LCGC Mrs. Matthews has nothing to disclose.
Andrea Hildebrand The institution of Ms. Hildebrand has received research support from National MS Society.
R J. Coryell, MD The institution of Dr. Coryell has received research support from Pediatric Epilepsy Research Foundation.
Laura Bliss, MD Dr. Bliss has nothing to disclose.
Ittai Bushlin, MD, PhD Dr. Bushlin has nothing to disclose.
Paul V. Motika, MD Dr. Motika has nothing to disclose.
Rishi Sharma, MD Dr. Sharma has nothing to disclose.
Jeremy K. Cutsforth-Gregory, MD, FAAN Dr. Cutsforth-Gregory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Ajay Madhavan Ajay Madhavan has nothing to disclose.
Brendan Putko, MD, MSc Dr. Putko has nothing to disclose.
Heidi Connolly, MD Dr. Connolly has nothing to disclose.
Marcus Vinicius R. Pinto, MD Dr. Pinto has nothing to disclose.
James Edwards, Medical Student Mr. Edwards has nothing to disclose.
Bohan Kim, BA Mr. Kim has nothing to disclose.
Amna M. Ali, BA Ms. Ali has nothing to disclose.
Jennifer Cheng, BS Ms. Cheng has nothing to disclose.
Ashish Balar, MBBS Dr. Balar has nothing to disclose.
Rajesh K. Gupta, MBBS Dr. Gupta has nothing to disclose.
Ivy Zheng, BSA Miss Zheng has nothing to disclose.
Rebecca A. Frawley, DO Dr. Frawley has nothing to disclose.
Ismat Babiker, MD Dr. Babiker has nothing to disclose.
Alejandro M. Blaubach, MD Dr. Blaubach has nothing to disclose.
Gabriella Garcia, MD Dr. Garcia has nothing to disclose.
Hadley Walsh, BA Ms. Walsh has nothing to disclose.
Matthew Somerville, MD Dr. Somerville has nothing to disclose.
Aubrey Hite, MS, CGC Mr. Hite has nothing to disclose.
Leah Chapman Leah Chapman has received research support from NIH and NINDS.
Jared M. Kaplan, MD Dr. Kaplan has nothing to disclose.
Audrey Hunt, DO Dr. Hunt has nothing to disclose.
Jennifer L. Harmon, MD, PhD Dr. Harmon has nothing to disclose.
Jessica Tate, MD The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Daniel Couture, MD Dr. Couture has nothing to disclose.
Jaclyn Martindale, DO, FAAN Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Stuart H. Isaacson, MD, FAAN The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Camilla Kilbane, MD, FAAN Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for acorda. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbvie. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kyowa kirin. Dr. Kilbane has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medronic. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for US world Meds. Dr. Kilbane has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Kilbane has received research support from Abbott.
Arkadiy N. Pitman, Biostatistician Mr. Pitman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal.
Richard D'Souza Richard DSouza has received personal compensation for serving as an employee of Amneal Pharmaceuticals. Richard DSouza has stock in Amneal Pharmaceuticals .
Ashkan Vaziri, PhD Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.
Ram Kinker Mishra, PhD Dr. Mishra has received personal compensation for serving as an employee of BioSensics LLC.
Adonay Nunes Adonay Nunes has nothing to disclose.
Zachary Simmons, MD, FAAN Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Andrew Geronimo The institution of Andrew Geronimo has received research support from BIoSensics.
Stella McCaughey, PhD Dr. McCaughey has received personal compensation for serving as an employee of Alector, Inc. Dr. McCaughey has received stock or an ownership interest from Alector, Inc.
Robert Reinecker, BA Mr. Reinecker has received personal compensation for serving as an employee of FTD Disorders Registry.
Bibek Samal, Student Mr. Samal has nothing to disclose.
Devin W. McBride, PhD The institution of Prof. McBride has received research support from APT Therapeutics, INC. Prof. McBride has received intellectual property interests from a discovery or technology relating to health care. Prof. McBride has received personal compensation in the range of $0-$499 for serving as a Grand Rounds Presenter with Barrow Neurological Institute.
Sungha Hong, PhD Dr. Hong has nothing to disclose.
Ari C. Dienel, PhD Dr. Dienel has nothing to disclose.
Ana-Marisa Lagman-Bartolome, MD Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Searchlight. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Lagman-Bartolome has received research support from AMGEN. The institution of Dr. Lagman-Bartolome has received research support from Abbvie. The institution of Dr. Lagman-Bartolome has received research support from Lundbeck. Dr. Lagman-Bartolome has received publishing royalties from a publication relating to health care.
James Im, MD Dr. Im has nothing to disclose.
Christine L. Lay, MD, FRCP Dr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Dr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Lay has received research support from Teva. The institution of Dr. Lay has received research support from Lundbeck.
Manav Vyas, MD The institution of Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . The institution of Dr. Vyas has received research support from Canadian Institutes of Health Research . Dr. Vyas has received research support from Heart and Stroke Foundation of Canada .
Ian Stanaitis, BMSc Mr. Stanaitis has nothing to disclose.
Elnara Fazio-Eynullayeva Ms. Fazio-Eynullayeva has received personal compensation for serving as an employee of Novo Nordisk. Ms. Fazio-Eynullayeva has stock in Novo Nordisk.
Lei Lv, PhD Dr. Lv has received personal compensation for serving as an employee of Novo Nordisk .
Paul Mystkowski, MD Dr. Mystkowski has received personal compensation for serving as an employee of Novo Nordisk. Dr. Mystkowski has stock in Novo Nordisk.
Caroline McKay, PhD Dr. McKay has received personal compensation for serving as an employee of Novo Nordisk. Dr. McKay has stock in Novo Nordisk. Dr. McKay has stock in Takeda. Dr. McKay has stock in Johnson & Johnson. Dr. McKay has stock in Merck.
Jordan Miller, PhD Dr. Miller has nothing to disclose.
Stephanie McKee Ms. McKee has received personal compensation for serving as an employee of Clarivate . Ms. McKee has stock in Clarivate .
Tamara Al-zubeidi, BSc Mrs. Al-zubeidi has received personal compensation for serving as an employee of Clarivate. Mrs. Al-zubeidi has stock in Clarivate analytics .
Catherine J. Bottomley, PhD Dr. Bottomley has received personal compensation for serving as an employee of Clarivate. Dr. Bottomley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka Pharmaceutical. An immediate family member of Dr. Bottomley has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Consulting. Dr. Bottomley has stock in Clarivate Analytics. The institution of an immediate family member of Dr. Bottomley has received research support from Skin Microbiome in Healthy Aging Consortium. The institution of an immediate family member of Dr. Bottomley has received research support from British Skin Foundation. Dr. Bottomley has received intellectual property interests from a discovery or technology relating to health care.
Catherine M. Floegel Ms. Floegel has received personal compensation for serving as an employee of Clarivate. Ms. Floegel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clarivate .
Richard Hyde Mr. Hyde has received personal compensation for serving as an employee of Clarivate.
Abdalla A. Aly, PhD Dr. Aly has received personal compensation for serving as an employee of Novo Nordisk Incorporated. Dr. Aly has stock in Novo Nordisk Incorporated.
Florian Then Bergh, MD Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actelion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fresenius. Dr. Then Bergh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. The institution of Dr. Then Bergh has received research support from Actelion. The institution of Dr. Then Bergh has received research support from Novartis. The institution of Dr. Then Bergh has received research support from DFG (German Science Fund). The institution of Dr. Then Bergh has received research support from Fresenius. The institution of Dr. Then Bergh has received research support from Diamed. Dr. Then Bergh has received personal compensation in the range of $10,000-$49,999 for serving as a Member of the Institutional Ethics Board with University of Leipzig, Medical Faculty.
Nicole Köppe-Bauernfeind Mrs. Köppe-Bauernfeind has nothing to disclose.
Clemens Goedel, MD Dr. Goedel has nothing to disclose.
Achim Berthele Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuraxpharm. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sabofi. Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Achim Berthele has received publishing royalties from a publication relating to health care.
Clemens Warnke The institution of Clemens Warnke has received research support from Novartis. The institution of Clemens Warnke has received research support from Alexion. The institution of Clemens Warnke has received research support from Sanofi-Genzyme. The institution of Clemens Warnke has received research support from Biogen. The institution of Clemens Warnke has received research support from Roche.
Muriel Stoppe Muriel Stoppe has nothing to disclose.
Claudius Küchle Dr. Küchle has nothing to disclose.
Martin R. Späth, MD Dr. Späth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fresenius Medical Care. Dr. Späth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SERB. The institution of Dr. Späth has received research support from Dr. Werner Jackstädt-Stiftung.
Annegret Franke, PhD Dr. Franke has nothing to disclose.
Azzam Ali, MBBS Mr. Ali has nothing to disclose.
Adarsh Raja Adarsh Raja has nothing to disclose.
Hamza Shuja, MBBS Mr. Shuja has nothing to disclose.
sandesh raja, MBBS Mr. raja has nothing to disclose.
Asfia Qammar, MD Mrs. Qammar has nothing to disclose.
Irving Fuentes Mr. Fuentes has nothing to disclose.
Mijail A. Rivas, Sr., MD Dr. Rivas has nothing to disclose.
Jimena Gonzalez Salido, MD Miss Gonzalez Salido has nothing to disclose.
Luis A. Marin-Castañeda, Sr. Mr. Marin-Castañeda has nothing to disclose.
Jimena Colado, MD Dr. Colado has nothing to disclose.
Fernando Vasquez Lopez, MD Dr. Vasquez Lopez has nothing to disclose.
Betsy C. Vazquez, MD Dr. Vazquez has nothing to disclose.
Eithel A. Valenzuela Mendivil Eithel A. Valenzuela Mendivil has nothing to disclose.
Salvador Martinez-Medina, MD Dr. Martinez-Medina has nothing to disclose.
Manuel Toledo Manuel Toledo has nothing to disclose.
Manuel Quintana, Sr., PhD Mr. Quintana has nothing to disclose.
Laura Abraira del Fresno, MD, PhD Dr. Abraira del Fresno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. Dr. Abraira del Fresno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Abraira del Fresno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. Dr. Abraira del Fresno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI.
Elena Fonseca, MD, PhD Dr. Fonseca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fonseca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Fonseca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Fonseca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Fonseca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma.
Aurelio J. Prado, PhD Prof. Prado has nothing to disclose.
Adriana Ochoa, PhD Dr. Ochoa has nothing to disclose.
Andrea Avalos Arias, MD Dr. Avalos Arias has nothing to disclose.
Jorge L. Guerrero, Sr., PhD Dr. Guerrero has nothing to disclose.
Mario Sebastian-Diaz, MD, PhD Dr. Sebastian-Diaz has nothing to disclose.
Iris E. Martinez-Juarez, MD No disclosure on file
Avinash S. Kolli, MD Dr. Kolli has nothing to disclose.
Jessica Singh Miss Singh has nothing to disclose.
Lincoln Darla, MD Dr. Darla has nothing to disclose.
Ukwen Akpoji, PharmD Dr. Akpoji has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Akpoji has received personal compensation for serving as an employee of Pfizer, Inc. Dr. Akpoji has stock in Alexion, AstraZeneca Rare Disease.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Shamik Bhattacharyya, MD, FAAN Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Aram Zabeti, MD Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zabeti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Zabeti has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Zabeti has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen . Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Kerstin Allen Kerstin Allen has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Kerstin Allen has stock in Alexion, AstraZeneca Rare Diseas.
Michelle R. Christie, MD Dr. Christie has nothing to disclose.
Lane Wimberly, MD Dr. Wimberly has received publishing royalties from a publication relating to health care.
Angela Shierk, PhD The institution of Dr. Shierk has received research support from American Occupational Therapy Foundation. The institution of Dr. Shierk has received research support from PCORI. The institution of Dr. Shierk has received research support from United Cerebral Palsy.
Linsley S. Smith, RN Mrs. Smith has nothing to disclose.
Manon Auffret, PhD, PharmD, DAAN Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aguettant. The institution of Dr. Auffret has received research support from Oxylis Medical. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Emmanuel NOWAK, PhD Mr. NOWAK has nothing to disclose.
Emmanuel OGER, MD, PhD Prof. OGER has nothing to disclose.
Marc Verin Mr. Verin has nothing to disclose.
Sandrine KERBRAT Mrs. KERBRAT has nothing to disclose.
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Laura Chisholm Laura Chisholm has nothing to disclose.
Ilene Hollin The institution of Ilene Hollin has received research support from MT Pharma. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from Shriners Hospital for Children. The institution of Ilene Hollin has received research support from NIH/NIDDK. The institution of Ilene Hollin has received research support from NIH/NHLBI. Ilene Hollin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with New Horizons, a division of Global Health Labs.
Hristelina S. Ilieva, MD The institution of Dr. Ilieva has received research support from ALSA. Dr. Ilieva has received personal compensation in the range of $0-$499 for serving as a reviewer with DOD.
Piera Pasinelli The institution of Dr. Pasinelli has received research support from NIH-NINDS.
Astrid Grouls, MD The institution of Dr. Grouls has received research support from ALS Association.
Julie Tram, MD Dr. Tram has nothing to disclose.
Janet N. Tamai, DO Dr. Tamai has nothing to disclose.
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Isha Snehal, MBBS Dr. Snehal has nothing to disclose.
Lorraine Siebold, MD, PhD Dr. Siebold has nothing to disclose.
Kelsey M. Smith, MD The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Elaine C. Wirrell, MD, FAAN Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Jeffrey W. Britton, MD, FAAN Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Lily Wong-Kisiel, MD, FAAN Dr. Wong-Kisiel has nothing to disclose.
Mittal S. Prajapati, MD Dr. Prajapati has nothing to disclose.
Richard Cheung Mr. Cheung has nothing to disclose.
Saif S. Bawaneh, MD Dr. Bawaneh has nothing to disclose.
Adeolu O. Morawo, MD Dr. Morawo has nothing to disclose.
Ali M. Al-Salahat, MBBS Dr. Al-Salahat has nothing to disclose.
Himanshu Verma, MBBS Dr. Verma has nothing to disclose.
Harshdeep Kaur, DO Miss Kaur has nothing to disclose.
Hassan Waseem Hassan Waseem has nothing to disclose.
Zain U. Abideen, MBBS Dr. Abideen has nothing to disclose.
Muhammad W. Ansari, MD Dr. Ansari has nothing to disclose.
Sania Aimen, MBBS Dr. Aimen has nothing to disclose.
Marium Khan Marium Khan has nothing to disclose.
Kiana Moussavi, MD Dr. Moussavi has nothing to disclose.
Alexander P. Auchus, MD, FAAN Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms.
Karen Beaty, MD Ms. Beaty has nothing to disclose.
Mengcui Gui The institution of Ms. Gui has received research support from Beijing Huikang Charity Foundation .
Jiayang Zhan, PhD Dr. Zhan has nothing to disclose.
Jing Lin, MD Dr. Lin has nothing to disclose.
yue li, MD, PhD Dr. li has nothing to disclose.
Bitao Bu, MD, PhD The institution of Prof. Bu has received research support from Beijing Huikang Charrity Foundation.
John Furey Mr. Furey has nothing to disclose.
Sara Feldman, PT Dr. Feldman has received personal compensation for serving as an employee of ALS Hope Foundation.
Zachary Bides Mr. Bides has nothing to disclose.
Jaroslaw Winniczek No disclosure on file
Meghan Conroy No disclosure on file
Kaitlyn Lillemoe, MD Dr. Lillemoe has nothing to disclose.
Sara K. Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
JULIA BEVILACQUA, NP Ms. BEVILACQUA has nothing to disclose.
Michela Rosso, MD Dr. Rosso has nothing to disclose.
Sungita Kumar, MD Dr. Kumar has nothing to disclose.
Carlos R. Camara-Lemarroy, MD Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for emd serono. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. Dr. Camara-Lemarroy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for novartis.
Heather Yong, MD Dr. Yong has nothing to disclose.
Ho Jin Kim, MD Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Elias S. Sotirchos, MD Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. The institution of Dr. Sotirchos has received research support from UCB. The institution of Dr. Sotirchos has received research support from Astoria Biologica. The institution of Dr. Sotirchos has received research support from Ad Scientiam. The institution of Dr. Sotirchos has received research support from Alexion. The institution of Dr. Sotirchos has received research support from Corevitas. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Veronica A. Tkachuk Veronica A. Tkachuk has nothing to disclose.
Sami Fam Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has or had stock in Astra Zeneca.
Lindsey Przybyl Lindsey Przybyl has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Lindsey Przybyl has stock in AstraZeneca.
Xiaoting Wang, MD Dr. Wang has nothing to disclose.
Arayamparambil Anilkumar, MD, FAAN Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Melissa Canales Miss Canales has nothing to disclose.
Ralph Habis, MD Dr. Habis has nothing to disclose.
Arun Venkatesan, MD, PhD Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
John Probasco, MD, FAAN Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech.
Khalil Husari, MD The institution of Dr. Husari has received research support from Maryland Innovation Initiative.
Jorge L. Vargas Rojas Mr. Vargas Rojas has nothing to disclose.
Ladan Ghazi Saidi, PhD The institution of Dr. Ghazi Saidi has received research support from Rosetta Stone. Dr. Ghazi Saidi has received personal compensation in the range of $0-$499 for serving as a Speaker with NSLHA.
Jane Roitsch, PhD Dr. Roitsch has nothing to disclose.
Nuria Montagut, PhD Dr. Montagut has nothing to disclose.
Crystal Hinrichs, MSEd, CCC-SLP The institution of Mrs. Hinrichs has received research support from Parkinson Voice Project.
Gracie A. Lopez, SLP Miss Lopez has nothing to disclose.
Nora Ko, MD Dr. Ko has nothing to disclose.
Vamshi K. Akula, DO Dr. Akula has nothing to disclose.
Nitya Mambalam No disclosure on file
Nataliya Ternopolska, MD Dr. Ternopolska has nothing to disclose.
Gillian Miller Ms. Miller has nothing to disclose.
Alexander L. Cohen, MD, PhD, FAAN The institution of Dr. Cohen has received research support from NIH. The institution of Dr. Cohen has received research support from Simons Foundation.
Marianna Leite Miss Leite has nothing to disclose.
Ana L. Morgado Miss Morgado has nothing to disclose.
Ana P. Cortines, Medical Student Mrs. Cortines has nothing to disclose.
Gabriel T. Candido, Graduando Mr. Candido has nothing to disclose.
Lizen Clare A. Moreira, Acadêmica Mrs. Moreira has nothing to disclose.
Carolina B. Moura, MD Dr. Moura has nothing to disclose.
Viviane T. Carvalho, MD Dr. Carvalho has nothing to disclose.
Raquel Q. da Costa, MD, PhD Prof. da Costa has nothing to disclose.
Nathane B. Rezende, MD Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Aztrazeneca. Dr. Rezende has received research support from ECTRIMS.
Gutemberg Santos No disclosure on file
Drew S. Kern, MD, FAAN Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Per Odin Per Odin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Britannia. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Convatec. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Tove Henriksen, MD Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nordic infucare. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Britannia. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for convatec. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nordic Infucare. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia.
Okeanis Vaou, MD, FAAN Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ABBVIE. Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Vaou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for medtronic. An immediate family member of Dr. Vaou has stock in SAGE. The institution of Dr. Vaou has received research support from Medtronic.
Lars Bergmann, MD Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.
Marie Omeara, Pharmacist Ms. Omeara has nothing to disclose.
Resmi Gupta Resmi Gupta has nothing to disclose.
Manon Bouchard, MD Dr. Bouchard has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Bouchard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Bouchard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Es Therapeutics. Dr. Bouchard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Bouchard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Bouchard has received research support from FRQS. Dr. Bouchard has received publishing royalties from a publication relating to health care.
Christine Gou, MD Dr. Gou has nothing to disclose.
Sean E. Smith, MD, MPHS Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inThought.
Ashley P. Ghiaseddin, MD, FAAN Dr. Ghiaseddin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neosoma. Dr. Ghiaseddin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Deciphera. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio. Dr. Ghiaseddin has or had stock in CRISPR Therapeutics AG.
Shatha S. Alqurashi Ms. Alqurashi has nothing to disclose.
Shahad M. Albeladi, Medical student Ms. Albeladi has nothing to disclose.
Saleha Almahdawi Miss Almahdawi has nothing to disclose.
Hala E. Danish, Medical Student Ms. Danish has nothing to disclose.
Hatoon Alshaikh Mr. Alshaikh has nothing to disclose.
Ahmed Alkhiri Mr. Alkhiri has nothing to disclose.
Mohammed Alqahtani Mohammed Alqahtani has nothing to disclose.
Ammar Al Kawi, MD, FAAN Dr. Al Kawi has nothing to disclose.
Fahad S. Al-Ajlan, MD Dr. Al-Ajlan has nothing to disclose.
Adel Alhazzani, MD, FRCPC, FAAN Dr. Alhazzani has nothing to disclose.
Said El Hage, MD Dr. El Hage has nothing to disclose.
Junaid M. Essa, DO Dr. Essa has nothing to disclose.
Kevin E. Kleine, DO Dr. Kleine has nothing to disclose.
Katherine A. Zarroli, MD Dr. Zarroli has nothing to disclose.
Jamir Pitton Rissardo, MD Dr. Pitton Rissardo has nothing to disclose.
Muhammad Abdullah Ali, MBBS Dr. Ali has nothing to disclose.
Ana Leticia Fornari Caprara, MD Dr. Fornari Caprara has nothing to disclose.
Vishnu V. Byroju, MD Dr. Byroju has nothing to disclose.
Umama Alam, MBBS Dr. Alam has nothing to disclose.
Marcus Milani Mr. Milani has nothing to disclose.
Omair Ul Haq Lodhi, MBBS Dr. Lodhi has nothing to disclose.
Haitham Hussein, MD, FAAN Dr. Hussein has nothing to disclose.
Richard A. Smith, MD Dr. Smith has received personal compensation for serving as an employee of Center for Neurologic Study. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Inventor with Ionis Pharmaceutical.
Russell Lebovitz, MD, PhD Dr. Lebovitz has received personal compensation for serving as an employee of Amprion . Dr. Lebovitz has received intellectual property interests from a discovery or technology relating to health care.
Hyunyong Koh, MD, PhD Dr. Koh has nothing to disclose.
Leslie Beltran, MD Dr. Beltran has nothing to disclose.
Sarah R. Risen, MD Dr. Risen has nothing to disclose.
Wataru Horiguchi, MD Dr. Horiguchi has nothing to disclose.
Daisuke Katagiri, MD, PhD Dr. Katagiri has nothing to disclose.
Takeyuki Watadani, MD, PhD Dr. Watadani has nothing to disclose.
Shunichi Matsuda, MD Dr. Matsuda has nothing to disclose.
Hiroshi Kaneko, MD Dr. Kaneko has nothing to disclose.
Noritoshi Arai, MD, PhD Dr. Arai has nothing to disclose.
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Laura Popper, MD Dr. Popper has received personal compensation for serving as an employee of Mapi Pharma.
Joseph R. Berger, MD, FAAN Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Alexey Boyko, MD, PhD No disclosure on file
Hadar Kolb Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Hadar Kolb has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MAPI pharma. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Scientific. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marck. The institution of Hadar Kolb has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI pharma. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison pharma. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marck.
Arnon Karni No disclosure on file
Ornit Almog Mrs. Almog has nothing to disclose.
Nadav Bleich Kimelman Nadav Bleich Kimelman has nothing to disclose.
Shai Rubnov Shai Rubnov has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Mapi pharma.
Uri Danon Uri Danon has received personal compensation for serving as an employee of Mapi harma.
Ehud Marom Mr. Marom has received personal compensation for serving as an employee of Mapi Pharma. Mr. Marom has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Mapi Pharma. Mr. Marom has stock in Mapi Pharma. Mr. Marom has received intellectual property interests from a discovery or technology relating to health care.
Richard Q. Vuong Mr. Vuong has nothing to disclose.
Valerie Morrill Ms. Morrill has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Tom Mosley, PhD Dr. Mosley has nothing to disclose.
Michelle C. Johansen, MD Dr. Johansen has received research support from NINDS/NIA. Dr. Johansen has received research support from American Heart Association.
Keenan Walker, PhD The institution of Dr. Walker has received research support from NIA/NIH.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
James R. Pike, MBA Mr. Pike has nothing to disclose.
Andrea L. Schneider, MD, PhD Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Rebecca F. Gottesman, MD, PhD The institution of Dr. Gottesman has received research support from NIH.
Yinan Zhao, PhD Mr. Zhao has nothing to disclose.
Said Alizada, MD Dr. Alizada has nothing to disclose.
ulvi samadzade, MD Dr. samadzade has nothing to disclose.
Nurbanu AYGUNDUZ YAPICI, MD Dr. AYGUNDUZ YAPICI has nothing to disclose.
Sumeyye Çevik, PhD Dr. Çevik has nothing to disclose.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Ela S. Zengin, MD Dr. Zengin has nothing to disclose.
Margil Ranpariya, MBBS Dr. Ranpariya has nothing to disclose.
Osman Farooq, MD Dr. Farooq has nothing to disclose.
Alexus P. Ludwig, DO Dr. Ludwig has nothing to disclose.
Abdullah Z. Alqahtani, MD Dr. Alqahtani has nothing to disclose.
Angela Kokkinis Angela Kokkinis has nothing to disclose.
Alice B. Schindler, MS, CGC Ms. SCHINDLER has nothing to disclose.
Jennifer Weinstein Jennifer Weinstein has nothing to disclose.
Nuran Dilek Nuran Dilek has nothing to disclose.
Charlotte Engebrecht Ms. Engebrecht has nothing to disclose.
Christina Shupe Ms. Shupe has nothing to disclose.
Chad R. Heatwole, MD, FAAN Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Christopher Grunseich, MD The institution of Dr. Grunseich has received research support from AnnJi Pharmaceuticals.
Naman D. Shah, MD Dr. Shah has nothing to disclose.
Michael S. Kung, MD Dr. Kung has nothing to disclose.
Rachel Pearson, MD Dr. Pearson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Pearson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Pediatric Subspecialty Faculy. The institution of Dr. Pearson has received research support from Pediatric Subspecialty Faculty.
John R. Crawford, MD Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Reibeck medical consulting.
Grace Kim, MD Grace Kim, MD has nothing to disclose.
Amal Hagouch, MD Dr. Hagouch has nothing to disclose.
Christian Bocti, MD Dr. Bocti has nothing to disclose.
Jimmy Li, MD Dr. Li has received research support from Fonds de recherche du Québec - Santé.
Aysha Kabbadj, MD Dr. Kabbadj has nothing to disclose.
Léa Proulx-Chartier, MD Miss Proulx-Chartier has nothing to disclose.
Ève Parenteau, Miss Miss Parenteau has nothing to disclose.
Denahin Hinnoutondji Toffa, MD, PhD, CSCN Dr. Toffa has nothing to disclose.
Natacha Rouillon, MD Dr. Rouillon has nothing to disclose.
Riana Schleicher Ms. Schleicher has nothing to disclose.
Rima Dafer, MD Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Zain Ashary, MD An immediate family member of Dr. Ashary has received personal compensation for serving as an employee of AbbVie.
Jordan Houser, MD Ms. Houser has nothing to disclose.
Deborah H. Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Kimberly Kwei, MD, PhD The institution of Dr. Kwei has received research support from New York Community Trust.
Nicollette L. Purcell, PhD Dr. Purcell has nothing to disclose.
Emily C. Timm The institution of Miss Timm has received research support from National Fragile X Foundation.
Rolando Acosta No disclosure on file
Bharatkumar Koyani, MBBS Mr. Koyani has received personal compensation for serving as an employee of Regeneron. Mr. Koyani has stock in Regeneron.
Erin E. Robertson, PhD, AuD Dr. Robertson has received personal compensation for serving as an employee of Regeneron Pharmaceuticals Inc. Dr. Robertson has stock in Regeneron Pharmaceuticals Inc.
Matthew F. Wipperman, PhD Dr. Wipperman has received personal compensation for serving as an employee of Regeneron Pharmaceuticals. Dr. Wipperman has stock in Regeneron Pharmaceuticals.
Oren Levy, MD Dr. Levy has received personal compensation for serving as an employee of Regeneron Pharmaceuticals . Dr. Levy has stock in Regeneron Pharmaceuticals .
Joan A. O'Keefe, PhD Dr. O'Keefe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Department of Defense.
Ibrahim Serag No disclosure on file
Mohamed Abouzid Mohamed Abouzid has nothing to disclose.
Ahmed Aljabali Ahmed Aljabali has nothing to disclose.
Ibraheem Alkhawaldeh Ibraheem Alkhawaldeh has nothing to disclose.
Mostafa El Din Moawad Mostafa El Din Moawad has nothing to disclose.
Ahmed Negida, MD, PhD Dr. Negida has nothing to disclose.
Md Mostafizur Rahman, MBBS, MS Dr. Rahman has nothing to disclose.
Willy Munyao, PhD Dr. Munyao has nothing to disclose.
Christopher Beauvil Mr. Beauvil has nothing to disclose.
Amatun Noor Prapty, MS Miss prapty has nothing to disclose.
Shangwen Yan Ms. Yan has nothing to disclose.
Ariana Badalov Ms. Badalov has nothing to disclose.
Nitya Sharma Miss Sharma has nothing to disclose.
Matteo Ruggiu, PhD Dr. Ruggiu has nothing to disclose.
Yong Yu, PhD Dr. Yu has received research support from National Institutes of Health (NIH).
Mohamed Mamdouh Mr. Mamdouh has nothing to disclose.
Anas Zakarya Nourelden, MD Dr. Nourelden has nothing to disclose.
Abdulrahman I. Hagrass, MBBS Mr. Hagrass has nothing to disclose.
Eid A. Mohamed, Sr., MBBS Dr. Mohamed has nothing to disclose.
Abdallah Kamal, MD Dr. Kamal has nothing to disclose.
Mohammed E. Elkholy, MD Dr. Elkholy has nothing to disclose.
Ibrahim Kamal, MD Dr. Kamal has nothing to disclose.
Ahmed H. Fathallah, MBBS Dr. Fathallah has nothing to disclose.
Andrea Meyers No disclosure on file
Patrick Gagnon-Sanschagrin No disclosure on file
Jessica Maitland No disclosure on file
Jenny Y. Park, PharmD, MS Dr. Park has received personal compensation for serving as an employee of Amgen Inc.. Dr. Park has or had stock in Amgen Inc..
FNU Shivangi, MBBS Dr. Shivangi has nothing to disclose.
Simranpreet Singh, MD Dr. Singh has nothing to disclose.
Nivedita Jha, MD, MBBS Dr. Jha has nothing to disclose.
Vaibhav Goswami, MD Dr. Goswami has nothing to disclose.
Faizan Shahzad Mr. Shahzad has nothing to disclose.
Marwah Bintay B. Khalid, MBBS Miss Khalid has nothing to disclose.
Momina R. Siddiqui, MBBS Miss Siddiqui has nothing to disclose.
Muhammad Zain-ul-Abedin Dr. Zain-ul-Abedin has nothing to disclose.
Saad Hulou Saad Hulou has nothing to disclose.
Besher Shami, MD Dr. Shami has nothing to disclose.
Syed Ijlal Ahmed, MD, MBBS Dr. Ahmed has nothing to disclose.
Julie Gallien Miss Gallien has nothing to disclose.
Pascal Dumont, Medical Student Mr. Dumont has nothing to disclose.
Veronique Duguay Miss Duguay has received research support from Research NB.
Dominique Comeau Dominique Comeau has nothing to disclose.
M'hamed Belkhodja, MLIS Mr. Belkhodja has nothing to disclose.
Ludivine Chamard Witkowski Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck Serono. The institution of Ludivine Chamard Witkowski has received research support from CFMNB. The institution of Ludivine Chamard Witkowski has received research support from Cantrain.
Mamadou Diallo, MD Dr. Diallo has nothing to disclose.
Mariama Boubacar Diallo Dr. Diallo has nothing to disclose.
Cisse Amara No disclosure on file
Souleymane Mbara Diallo No disclosure on file
Haishan Jiao, PhD Dr. Jiao has nothing to disclose.
Muhammad H. Khan Mr. Khan has nothing to disclose.
Gulbudin Muhammad, MD Dr. Muhammad has nothing to disclose.
Hira Pervez, MD, MBBS Dr. Pervez has nothing to disclose.
Fahham Asghar, MD Mr. Asghar has nothing to disclose.
Syed Owais, MD Dr. Owais has nothing to disclose.
Naeem Mahfooz, MD Dr. Mahfooz has nothing to disclose.
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Ying Huang The institution of Miss Huang has received research support from Shenzhen Science and Technology Program.
Qianhui Xu, MD Dr. Xu has nothing to disclose.
Arman Cakar No disclosure on file
Sezan Mergen Kiliç, PT Mrs. Mergen KILIÇ has nothing to disclose.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Isabelle H. Kang Ms. Kang has nothing to disclose.
Ashley Sablich, MD Dr. Sablich has nothing to disclose.
Heba Akbari, MD Dr. Akbari has nothing to disclose.
Wenya Chen, PhD Ms. Chen has nothing to disclose.
Alma R. Bicknese, MD Dr. Bicknese has nothing to disclose.
Anisa Kelley, MD Dr. Kelley has nothing to disclose.
Samuel D. Blizzard Mr. Blizzard has nothing to disclose.
Kelvin L. Chou, MD, FAAN Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. The institution of Dr. Chou has received research support from NIH. The institution of Dr. Chou has received research support from Parkinson Study Group. The institution of Dr. Chou has received research support from Michael J Fox Foundation. The institution of Dr. Chou has received research support from Cerevance. Dr. Chou has received publishing royalties from a publication relating to health care. Dr. Chou has received publishing royalties from a publication relating to health care.
Sagar Vaidya, MD, PhD Dr. Vaidya has received personal compensation for serving as an employee of Cerevance. Dr. Vaidya has received intellectual property interests from a discovery or technology relating to health care.
Nicola Brice, PhD Dr. Brice has received personal compensation for serving as an employee of Cerevance.
Celina Scholl, Doctor of Physical Therapy Dr. Scholl has nothing to disclose.
Michelle Charles, MPH Mrs. Charles has received personal compensation for serving as an employee of Cerevance Inc..
Lee Dawson, PhD Dr. Dawson has received personal compensation for serving as an employee of Cerevance Ltd. Dr. Dawson has stock in Cerevance Ltd.
Mark Carlton, PhD Dr. Carlton has received personal compensation for serving as an employee of Cerevance. Dr. Carlton has stock in Cerevance.
Aishwarya Koppanatham, MBBS Ms. Koppanatham has nothing to disclose.
Mirza Ammar Arshad Mr. Arshad has nothing to disclose.
komal zulfiqar, MBBS Dr. zulfiqar has nothing to disclose.
Abu Huraira Bin Gulzar Mr. Bin Gulzar has nothing to disclose.
Umair Ahmed, MD, MBBS Dr. Ahmed has nothing to disclose.
Naga Pradyumna Kothapalli, MD Dr. Kothapalli has nothing to disclose.
Yong Guo Yong Guo has nothing to disclose.
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Fernando X. Cuascut Lassus, MD Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving as a Speaker with MSAA.
Hemali Patel, DO Dr. Patel has nothing to disclose.
W. O. Tobin, PhD, MBBCh, BAO, FAAN Dr. Tobin has received publishing royalties from a publication relating to health care.
Mark Keegan, MD, FAAN Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Musisye Luchembe Musisye Luchembe has nothing to disclose.
Deanna Saylor, MD, MHS Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Melody T. Asukile, MBBS Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Lorraine Chishimba, MBChB, MMED Dr. Chishimba has nothing to disclose.
Stanley Zimba, MBBS Dr. Zimba has nothing to disclose.
Mashina Chomba, MBChB Dr. Chomba has nothing to disclose.
Meron Gebrewold, MD Dr. Gebrewold has nothing to disclose.
Aparna Nutakki, MD Ms. Nutakki has received research support from UJMT Fogarty Global Health Fellowship Program. Ms. Nutakki has received research support from AAN Medical Student Research Scholarship. Ms. Nutakki has received research support from Gold Humanism Student Summer Fellowship.
Sarah Braun, MD Sarah Braun has nothing to disclose.
Mataa Mataa, MD Mataa Mataa has nothing to disclose.
Dominique Mortel, MD Dr. Mortel has nothing to disclose.
Mulenga Chilando Mulenga Chilando has nothing to disclose.
Dickson Munkombwe, MD Dr. Munkombwe has nothing to disclose.
Faith Simushi, MD Dr. Simushi has received research support from American Neurological Association - ANA.
Coolwe Namangala Dr. Namangala has nothing to disclose.
Naluca Mwendaweli, MMED NALUCA MWENDAWELI has nothing to disclose.
Frighton B. Mutete, MBChB Dr. Mutete has nothing to disclose.
Maria Gonzalez, MD Dr. Gonzalez has nothing to disclose.
Manasa Sudheendra, MBBS Dr. Sudheendra has nothing to disclose.
Aishwarya Pareek, MD No disclosure on file
Peter W. Campbell, MD, PhD Dr. Campbell has nothing to disclose.
Bhavani Kashyap, MBBS, PhD Dr. Kashyap has nothing to disclose.
Leah R. Hanson, PhD The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
Julia C. Johnson, MD The institution of Dr. Johnson has received research support from HealthPartners.
Sally Gustafson Sally Gustafson has nothing to disclose.
Kathryn Wyman-Chick, Psyd Dr. Wyman-Chick has received research support from NIH/NIA.
Meghan O'Brien, MPH The institution of Miss O'Brien has received research support from National Institutes of Health.
William H. Frey II, PhD Dr. Frey has stock in IntrepiCyte, LLC. The institution of Dr. Frey has received research support from United States Department of Defense. Dr. Frey has received intellectual property interests from a discovery or technology relating to health care. Dr. Frey has received intellectual property interests from a discovery or technology relating to health care.
Aleta Svitak, MS Aleta Svitak has nothing to disclose.
Gianmarco Severa, MD Dr. Severa has received research support from Généthon, UPEC.
Christophe Alimi, PT Mr. Alimi has nothing to disclose.
Edoardo Malfatti, MD Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.
Juan D. Martinez Lemus, MD Dr. Martinez Lemus has nothing to disclose.
Mya C. Schiess, MD, FAAN Dr. Schiess has nothing to disclose.
Emily Tharp, MD Dr. Tharp has nothing to disclose.
Vanessa K. Thyne, MSc Ms. Thyne has nothing to disclose.
Chiamaka C. Onuigbo, MD Dr. Onuigbo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal.
Tran B. Le, MD Dr. Le has nothing to disclose.
Robert Ritter III Mr. Ritter has nothing to disclose.
Elia Sechi, MD Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Pietro Zara, MD Dr. Zara has nothing to disclose.
Stefania Leoni, Sr., MD, PhD Dr. Leoni has nothing to disclose.
Sara Etzi Dr. Etzi has nothing to disclose.
Sabrine Othmani, MD Dr. Othmani has nothing to disclose.
Valentina Floris, MD Dr. Floris has nothing to disclose.
maria margherita sechi, MD Dr. sechi has nothing to disclose.
Rosa Cortese No disclosure on file
Matteo Gastaldi, MD, PhD Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion, Roche, UCB, J&J. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health, FISM, AE alliance.
Sara Mariotto, MD, PhD Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, AAN. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck. The institution of Dr. Mariotto has received research support from Euroimmun. The institution of Dr. Mariotto has received research support from FISM.
Stefano Sotgiu Stefano Sotgiu has nothing to disclose.
Paolo Solla, MD Dr. Solla has nothing to disclose.
Joy Youn Miss Youn has nothing to disclose.
David Castro David Castro has nothing to disclose.
John Newman John Newman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Junevity. John Newman has or had stock in BHB Therapeutics.John Newman has or had stock in Selah Therapeutics.John Newman has or had stock in BOPZ. The institution of John Newman has received research support from NIH. The institution of John Newman has received research support from Hevolution Foundation. The institution of John Newman has received research support from ARPA-H. The institution of John Newman has received research support from US Department of Defense. The institution of an immediate family member of John Newman has received research support from The Fibrolamellar Cancer Foundation. John Newman has received intellectual property interests from a discovery or technology relating to health care. John Newman has received intellectual property interests from a discovery or technology relating to health care. John Newman has received intellectual property interests from a discovery or technology relating to health care. John Newman has received publishing royalties from a publication relating to health care. An immediate family member of John Newman has received personal compensation in the range of $500-$4,999 for serving as a Committee Voting Member with NIH. John Newman has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer with NIH. John Newman has received personal compensation in the range of $500-$4,999 for serving as a DSMB Member with NIH.
Vanja C. Douglas, MD, FAAN Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Sara LaHue, MD The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Longevity Impetus Grants. Dr. LaHue has received publishing royalties from a publication relating to health care.
Mohammed B. Baker Mr. Baker has nothing to disclose.
Haneen Aljaiuossi, MD Miss Aljaiuossi has nothing to disclose.
Dina T. Badawi, MD Dr. Badawi has nothing to disclose.
Mohammad O. Al-Khawaldeh, MD Dr. Al-Khawaldeh has nothing to disclose.
Leen G. Alsayeh, OT Ms. Alsayeh has nothing to disclose.
Yazan Badie Jalil EL-Dayeh Mr. EL-Dayeh has nothing to disclose.
Sadeen Eid Sadeen Eid has nothing to disclose.
Amer Jaradat, MD Dr. Jaradat has nothing to disclose.
Ankur Vivek Ankur Vivek has nothing to disclose.
Arpan Mitra, MD Dr. Mitra has nothing to disclose.
Nayana Bhuyan, MD Dr. Bhuyan has nothing to disclose.
Akansha Jain, MD Dr. Jain has nothing to disclose.
Rafael A. Aguiar Mr. Aguiar has nothing to disclose.
Gabriel A. Araujo, Medical student Mr. ARAUJO has nothing to disclose.
Lucas M. Linhares Mr. Linhares has nothing to disclose.
Layla C. Benevides Ms. Benevides has nothing to disclose.
Bianca V. Pinheiro Miss Pinheiro has nothing to disclose.
Samuel Luca R. Pinheiro Mr. Pinheiro has nothing to disclose.
Antonia Campelo, Medical Student Miss Campelo has nothing to disclose.
LUIS H. REGO, Student Mr. REGO has nothing to disclose.
Pedro L. Carvalho Mr. Carvalho has nothing to disclose.
Artur Menegaz de Almeida, MS Mr. Menegaz de Almeida has nothing to disclose.
Alice R. Silva, Medical student Ms. Silva has nothing to disclose.
Parth A. Ladha, MBBS Dr. Ladha has nothing to disclose.
Suban Amatya Suban Amatya has nothing to disclose.
Rutvik M. Savaliya, MBBS Dr. Savaliya has nothing to disclose.
Sema Akkus, MD Dr. Akkus has nothing to disclose.
Jian Xu, MD, PhD Dr. Xu has nothing to disclose.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Dinesh Lulla, MD Dr. Lulla has nothing to disclose.
Yusuf Kagzi Mr. Kagzi has nothing to disclose.
Prachi Raichur, MD Dr. Raichur has nothing to disclose.
Saad Hasan, MD Dr. Hasan has nothing to disclose.
Seema Mian, MD Miss Mian has nothing to disclose.
Madison Little, MD Dr. Little has nothing to disclose.
Ramsey Amoudi, MS Mr. Amoudi has nothing to disclose.
Ruolan Liu, PhD Dr. Liu has nothing to disclose.
Chimaobi Ochulo Mr. Ochulo has nothing to disclose.
Raquel Costa, PharmD, SpLM Dr. Costa has nothing to disclose.
Miguel M. Fonseca, PhD Mr. Fonseca has received personal compensation for serving as an employee of Bial.
Francisco Rocha Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Joerg Holenz, PhD Mr. Holenz has received personal compensation for serving as an employee of BIAL. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAL RD Investments. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAl Portela SA. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAL Biotech . Mr. Holenz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Mr. Holenz has stock in Astra Zeneca. Mr. Holenz has received intellectual property interests from a discovery or technology relating to health care.
Joana L. Almeida, MD Dr. Almeida has received personal compensation for serving as an employee of Bial.
Joaquim Ferreira No disclosure on file
Miguel F. Gago, MD, PhD Prof. Gago has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Prof. Gago has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Prof. Gago has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon.
Helena Brigas, PhD Dr. Brigas has received personal compensation for serving as an employee of BIAL.
Rachel L. Schuurs, MD Miss Schuurs has nothing to disclose.
James Bates, Medical Student Mr. Bates has nothing to disclose.
Dominic L. Julian Mr. Julian has nothing to disclose.
James Kelbert Mr. Kelbert has nothing to disclose.
Christina Chrisman, MD Dr. Chrisman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Chrisman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Chrisman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Chrisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson.
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Bryan Traynor, MD The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Prisha Nanda Kumar, Medical Student Ms. Nanda Kumar has nothing to disclose.
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Ethan G. Brown, MD Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Kathleen Comyns Kathleen Comyns has nothing to disclose.
Monica Korell, MPH Ms. Korell has nothing to disclose.
Cheryl Meng, MPH Miss Meng has nothing to disclose.
Xuejie Chen, PhD Dr. Chen has nothing to disclose.
Adrienne L. Clark Ms. Clark has nothing to disclose.
Julien Valverde Twiggs Mr. Valverde Twiggs has nothing to disclose.
Nauman Abid, MD Dr. Abid has received personal compensation for serving as an employee of BlueRock Therapeutics.
Whitney Stemple Whitney Stemple has received personal compensation for serving as an employee of BlueRock Therapeutics.
Madhu Kumar Komuravelli Mr. Komuravelli has nothing to disclose.
Dennis Huang, MD Dr. Huang has nothing to disclose.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Namita Goyal, MD, FAAN Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Jeffrey Mullen, MD Dr. Mullen has nothing to disclose.
Gabriella Law Ms. Law has nothing to disclose.
Micah Hamilton Mr. Hamilton has nothing to disclose.
Shakti Nayar, MD Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Nicholas S. Streicher, MD Dr. Streicher has nothing to disclose.
Pranay Marlecha Dr. Marlecha has nothing to disclose.
Sweta Sahu Dr. Sahu has nothing to disclose.
Tirath Patel, MD Mr. Patel has nothing to disclose.
Khushi V. Singh Dr. Singh has nothing to disclose.
Nikhilesh Anand, MD Dr. Anand has nothing to disclose.
Bharathi Gadad, PhD Dr. Gadad has nothing to disclose.
Hamilton Roberto Moreira de Oliveira Carrico Mr. Roberto Moreira de Oliveira Carrico has nothing to disclose.
Carolina N. Calderoni, MS Ms. Calderoni has nothing to disclose.
Andreza F. Amaral III, MS Mrs. Amaral has nothing to disclose.
Carolina M. Vieira Mrs. Vieira has nothing to disclose.
Denisarth Oliveira Nery Filho, Sr., MS (Medical Student) Mr. Oliveira Nery Filho has nothing to disclose.
Wingrid Raiane Barreto Goncalves Conceicão, MS Miss Barreto Goncalves Conceicão has nothing to disclose.
Larissa E. Tanimoto, student Miss Tanimoto has nothing to disclose.
Pedro Henrique de Souza Wagner, Medical Student Mr. DE SOUZA WAGNER has nothing to disclose.
Aida Akhoundi, MD Dr. Akhoundi has nothing to disclose.
Bahram Haghi Ashtiani, MD Dr. Haghi Ashtiani has nothing to disclose.
Armin Ariaei Mr. Ariaei has nothing to disclose.
Davoud Kamali, MD Dr. Kamali has nothing to disclose.
Mohamad Taghi Tajik Jalayeri, MD Dr. tajik jalayeri has nothing to disclose.
Alireza Salmanipour, MD Dr. Salmanipour has nothing to disclose.
Maryam Rezaee, MD Dr. rezaee has nothing to disclose.
Obai M. Yousef, Sr., MD Dr. Yousef has nothing to disclose.
Moaz E. Abouelmagd, MD Dr. Abouelmagd has nothing to disclose.
Ismail A. Ibrahim Mr. Ibrahim has nothing to disclose.
Ahmed Elshahat, MD Dr. Elshahat has nothing to disclose.
Muhammad Jansher, MBBS Mr. Jansher has nothing to disclose.
Muhammad Sohaib Khan Mr. Khan has nothing to disclose.
Wania Moeen Dr. Moeen has nothing to disclose.
Ali K. Tareen, MBBS Mr. Tareen has nothing to disclose.
Fakhar Latif Mr. Latif has nothing to disclose.
Rooma Rehan, MBBS Ms. Rehan has nothing to disclose.
Muzamil Khan, MBBS Dr. Khan has nothing to disclose.
Waseem Nabi, MD Dr. Nabi has nothing to disclose.
Maryam Inam Zaroo, MBBS Dr. Zaroo has nothing to disclose.
Mohammad Danish, MBBS Mr. Danish has nothing to disclose.
Vivek Sanker, MBBS Dr. Sanker has nothing to disclose.
Arif Dalvi, MD Dr. Dalvi has received personal compensation in the range of $0-$499 for serving as a Consultant for Insightec. Dr. Dalvi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia Pharmaceuticals. The institution of Dr. Dalvi has received research support from Insightec.
Lloyd Zucker, MD Dr. Zucker has received research support from Insightec .
WEI CHIEH CHANG, MD Dr. CHANG has nothing to disclose.
Peihan Wu, MD Dr. Wu has nothing to disclose.
Michael Kaplitt, MD No disclosure on file
Howard Eisenberg No disclosure on file
Paul S. Fishman, MD, PhD No disclosure on file
Vivek Buch Vivek Buch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Vivek Buch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace.
Michele Matarazzo, MD Dr. Matarazzo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Matarazzo has received research support from Michael J Fox Foundarion.
MARTA DEL ALAMO, MD Dr. DEL ALAMO has nothing to disclose.
Lain Hermes Gonzalez-Quarante, MD Dr. Gonzalez-Quarante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Gonzalez-Quarante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Gonzalez-Quarante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rebrain. Dr. Gonzalez-Quarante has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PALEX.
Maria C. Rodriguez-Oroz, MD, PhD Dr. Rodriguez-Oroz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec . Dr. Rodriguez-Oroz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rodriguez-Oroz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Insightec . Dr. Rodriguez-Oroz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez-Oroz has received research support from Spanish Government. The institution of Dr. Rodriguez-Oroz has received research support from Goverment of Navarra.
Sepehr Sani The institution of Sepehr Sani has received research support from NIH. Sepehr Sani has received intellectual property interests from a discovery or technology relating to health care. Sepehr Sani has received publishing royalties from a publication relating to health care.
Michael Pourfar, MD Dr. Pourfar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Pourfar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott.
Alon Mogilner, MD, PhD Dr. Mogilner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medtronic.
Gaganjot K. Sooch, MS, MBA Mrs. Sooch has received personal compensation for serving as an employee of Insightec.
Cyril Ferrer, PhD Dr. Ferrer has received personal compensation for serving as an employee of Inisghtec Europe GmbH.
Katie Gant Katie Gant has received personal compensation for serving as an employee of Insightec .
Augusto Grinspan, MD Dr. Grinspan has received personal compensation for serving as an employee of Insightec.
Theresa Nair, MPH Ms. Nair has nothing to disclose.
Theodore Larson Theodore Larson has nothing to disclose.
Jaime Raymond Jaime Raymond has nothing to disclose.
D Kevin Horton No disclosure on file
Paul Mehta Paul Mehta has nothing to disclose.
Peter A. LeWitt, MD Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Sharina Reyes Dr. Reyes has nothing to disclose.
Andrea Formella, PharmD, BCPP Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..
Gianpiera Ceresoli-Borroni, PhD Dr. Ceresoli-Borroni has nothing to disclose.
Muddasu Suhasini Keerthipriya, MBBS Dr. Keerthipriya has nothing to disclose.
Seena Vengalil, MD Dr. Vengalil has nothing to disclose.
Nalini Atchayaram, MD, PhD Prof. Atchayaram has nothing to disclose.
Priya Thomas, PhD Dr. Thomas has nothing to disclose.
GAUTHAM ARUNACHAL, MD Dr. ARUNACHAL has nothing to disclose.
Saraswati Nashi, MD Dr. Nashi has nothing to disclose.
Daniel Kremens, MD, JD, FAAN Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Neurocrine. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Kremens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for UCB.
Milan Joshi Mr. Joshi has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc..
Mindy Grall, PhD, NP Ms. Grall has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Ms. Grall has or had stock in Supernus.
Ebru Erzurumluoglu Gokalp, PhD Dr. Erzurumluoglu Gokalp has nothing to disclose.
Duygu Gezen-Ak, PhD Prof. Gezen-Ak has nothing to disclose.
Erdinc Dursun, PhD Prof. Dursun has nothing to disclose.
Zehra O. Uyguner, PhD Prof. Uyguner has nothing to disclose.
Esen Kiyan ESEN KIYAN has nothing to disclose.
Merve Alaylioglu, PhD Dr. Alaylioglu has nothing to disclose.
Nikkilina Crouse, PhD Dr. Crouse has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. . Dr. Crouse has stock in Supernus Pharmaceuticals, Inc.
Arianne Breiteneicher Arianne Breiteneicher has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Arianne Breiteneicher has stock in Supernus Pharmaceuticals.
Emanuelly L. Barbosa Ms. Barbosa has nothing to disclose.
Frederico M. de Sousa Marinho Mendes Filho Mr. de Sousa Marinho Mendes Filho has nothing to disclose.
David B. Abraham, MS Mr. Abraham has nothing to disclose.
Elizabet Taylor P. Weba, Jr., Student Miss Weba has nothing to disclose.
Luis O. Nogueira, medical student Mr. NOGUEIRA has nothing to disclose.
Rahma A. Ibrahim Ms. Ibrahim has nothing to disclose.
Ahmed S. Fathy, Jr., student Dr. Fathy has nothing to disclose.
Ahmed M. Shaheen Dr. Shaheen has a non-compensated relationship as a A Research Position Candidate Under Trial Task with Solvemed Company that is relevant to AAN interests or activities.
Ahmed Nazmy, MBBS Dr. Abd El Aziz has nothing to disclose.
Salma N. Nasser, MD Dr. Nasser has nothing to disclose.
Nada A. Hegazy, PhD Dr. Hegazy has nothing to disclose.
Ram K. Saha, MD Dr. Saha has nothing to disclose.
Yousef H. Saad, Jr., MD Mr. Saad has nothing to disclose.
Xiaoli YAO, MD Prof. YAO has nothing to disclose.
Sen Huang, MD, PhD Dr. Huang has nothing to disclose.
Mingying Zheng No disclosure on file
Xinyu Yang, MD No disclosure on file
Youna Xie, PhD Dr. XIE has nothing to disclose.
zhanhua Zhong Ms. Zhong has nothing to disclose.
Yuxin Wang II, MD Miss Wang has nothing to disclose.
Ikjae Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Spastic Paraplegia Foundation.
Kathleen Stolwyk, RD Mrs. Stolwyk has nothing to disclose.
Matthew Harms, MD Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Harms has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Muscular Dystrophy Association. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Invitae. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Variant Bio. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Dr. Harms has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Littlepage Booth. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for O'Connor First. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Searcy Denney. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ford, Parshall & Baker LLC . The institution of Dr. Harms has received research support from ALS Association. The institution of Dr. Harms has received research support from Ionis. The institution of Dr. Harms has received research support from ALS Finding a Cure. The institution of Dr. Harms has received research support from Target ALS.
Jinsy Andrews, MD, FAAN Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Meyer Squibb. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from ALS Platform Trial . The institution of Dr. Andrews has received research support from Corcept.
Jiyoon Hwang, MPH Ms. Hwang has nothing to disclose.
Neil A. Shneider, MD, PhD Dr. Shneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Shneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Shneider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ProJenX. Dr. Shneider has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Shneider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GLG. Dr. Shneider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Guidepoint. The institution of Dr. Shneider has received research support from Merck Sharp & Dohme. The institution of Dr. Shneider has received research support from National Institutes of Health. The institution of Dr. Shneider has received research support from ALS Association. The institution of Dr. Shneider has received research support from DoD/CDMRP - ALSRP. The institution of Dr. Shneider has received research support from Target ALS. The institution of Dr. Shneider has received research support from Ionis Pharmaceutical. The institution of Dr. Shneider has received research support from Cellenkos.
Jaskeerat Gujral, BA Mr. Gujral has nothing to disclose.
William Rodemer, PhD Dr. Rodemer has nothing to disclose.
Elizabeth Jia Miss Jia has nothing to disclose.
Samuel Rekulak Mr. Rekulak has nothing to disclose.
Halvor Juul, PhD Dr. Juul has nothing to disclose.
Irene Ra, BA Ms. Ra has nothing to disclose.
silvia porta, PhD Miss porta has nothing to disclose.
Delia Maria Talos, MD The institution of Dr. Talos has received research support from NIH. Dr. Talos has received personal compensation in the range of $0-$499 for serving as a Scientific reviewer with NIH. Dr. Talos has received personal compensation in the range of $0-$499 for serving as a Scientific reviewer with DOD.
Virginia Lee, PhD Virginia Lee, PhD has nothing to disclose.
Alexis B. Coalson, DO Dr. Coalson has nothing to disclose.
James Grogan, MD Dr. Grogan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Patrick J. Bergquist, MD Dr. Bergquist has nothing to disclose.
Jordan M. Yaukey, DO Dr. Yaukey has nothing to disclose.
Ibrahim Serag, MD Dr. Serag has nothing to disclose.
Amanda E. Macone, MD Dr. Macone has nothing to disclose.
Linda G. Baer, MSPH, CHCP Ms. Baer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Stanford University. Ms. Baer has received personal compensation in the range of $50,000-$99,999 for serving as a COO with ECHO Diabetes Action Network.
Julie L. White, MS Ms. White has nothing to disclose.
Natalie Sanfratello, MPH Ms. Sanfratello has nothing to disclose.
Horacio M. Rodriguez Mr. Rodriguez has nothing to disclose.
Amber Lemons, PharmD Dr. Lemons has nothing to disclose.
Surabhi A. Garg, MD Dr. Garg has nothing to disclose.
Tiago Mestre, MD, MSC Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CHDI. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mestre has received research support from CIHR. The institution of Dr. Mestre has received research support from Ontario Research Fund. The institution of Dr. Mestre has received research support from MJFF. The institution of Dr. Mestre has received research support from Parkinson Canada. The institution of Dr. Mestre has received research support from University of Ottawa/PRC.
Joshua Keses, Student Mr. Keses has nothing to disclose.
Glenn T. Stebbins, PhD Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Thomas C. Varkey, MD Dr. Varkey has nothing to disclose.
Federico Montini Mr. Montini has nothing to disclose.
Luke Schwerdtfeger, PhD Dr. Schwerdtfeger has nothing to disclose.
Jonathan D. Zurawski, MD The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation. The institution of Dr. Zurawski has received research support from Novartis.
Shahamat Tauhid, MD Dr. Tauhid has nothing to disclose.
Molly Quattrucci Molly Quattrucci has nothing to disclose.
Alexis Callen Alexis Callen has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Laura M. Cox Dr. Cox has received personal compensation for serving as an employee of Anaerobe Systems.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Salvador Sierra, MD, PhD Dr. Sierra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint .
Anna Kratz No disclosure on file
Tiffany Braley, MD Dr. Braley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluestar BioAdvisors. The institution of Dr. Braley has received research support from NIH. The institution of Dr. Braley has received research support from PCORI. The institution of Dr. Braley has received research support from National Multiple Sclerosis Society.
Jeremias Antinew Jeremias Antinew has received personal compensation for serving as an employee of Pfizer Inc.
Robert Fountaine Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has or had stock in Pfizer, Inc.Robert Fountaine has or had stock in Viatris, Inc.
Vittorio Loprinzo, PhD Dr. Loprinzo has received personal compensation for serving as an employee of Pfizer, Inc. Dr. Loprinzo has stock in Pfizer, Inc.
Esther Straghan Esther Straghan has nothing to disclose.
Terence Fullerton, PharmD Dr. Fullerton has received personal compensation for serving as an employee of Pfizer. Dr. Fullerton has stock in Pfizer.
Marina Scop Medeiros, MD Dr. Scop Medeiros has nothing to disclose.
Pamela Lukasewicz Ferreira Dr. Lukasewicz Ferreira has nothing to disclose.
Bruna Bellaver, PhD Dr. Bellaver has nothing to disclose.
Emma Ruppert, MD Dr. Ruppert has nothing to disclose.
Hussein Zalzale, MD Dr. Zalzale has nothing to disclose.
Carolina Soares, PhD Dr. Soares has nothing to disclose.
Guilherme Bauer-Negrini, PhD Dr. Bauer-Negrini has nothing to disclose.
Guilherme Povala, PhD Dr. Povala has nothing to disclose.
Livia Silva do Amaral Mrs. Silva do Amaral has nothing to disclose.
Firoza Lussier, MS Ms. Lussier has nothing to disclose.
Dana L. Tudorascu, PhD Dr. Tudorascu has nothing to disclose.
Joseph C. Masdeu, MD, PhD, FAAN Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
David N. Soleimani-Meigooni, MD Dr. Soleimani-Meigooni has nothing to disclose.
Juan Fortea, MD, PhD Dr. Fortea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Inmune. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Fortea has received research support from NIH. Dr. Fortea has received intellectual property interests from a discovery or technology relating to health care.
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Hwamee Oh, PhD The institution of Dr. Oh has received research support from NIH.
Belen Pascual, PhD The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Brian Gordon, PhD Dr. Gordon has nothing to disclose.
Pedro Rosa Neto, MD, PhD Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.
Lucas Porcello Schilling Dr. PORCELLO SCHILLING has nothing to disclose.
Suzanne Baker, PhD The institution of Miss Baker has received research support from National Institute of Health.
Tharick A. Pascoal, Sr., MD, PhD Dr. Pascoal has nothing to disclose.
Hyorin Hwang Miss hwang has nothing to disclose.
Min Hak Lee, MBBS Mr. Lee has nothing to disclose.
Jintak Cha Mr. Cha has nothing to disclose.
Ben M. Illigens, MD Dr. Illigens has received personal compensation for serving as an employee of Target Health. Dr. Illigens has received personal compensation for serving as an employee of BC Platforms. Dr. Illigens has received personal compensation for serving as an employee of NOVA Discovery. Dr. Illigens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RDP Pharma. Dr. Illigens has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Biomind Labs. Dr. Illigens has a non-compensated relationship as a Director with Partners for Patients that is relevant to AAN interests or activities.
Charles McKenna, PhD Dr. McKenna has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bird and Bird. Dr. McKenna has stock in BioVinc LLC. The institution of Dr. McKenna has received research support from NIH. Dr. McKenna has received intellectual property interests from a discovery or technology relating to health care.
Jin Woo Choi, PhD Prof. Choi has nothing to disclose.
Kyunghwa Baek, PhD Prof. Baek has nothing to disclose.
Karl Hansen Dr. Hansen has received personal compensation for serving as an employee of Praxis Precision Medicines.
Silvana Frizzo, MD Dr. Frizzo has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Frizzo has stock in Praxis Precision Medicines.
Henry Jacotin Henry Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Henry Jacotin has stock in Praxis Precision Medicines. Henry Jacotin has stock in Clover Health. Henry Jacotin has stock in Certara. Henry Jacotin has stock in Takeda. Henry Jacotin has received personal compensation in the range of $500,000-$999,999 for serving as a VP Clinical Development and Pharmacovigilance with Praxis Precision Medicines.
Dharit Patel, MD Mr. Patel has received personal compensation for serving as an employee of Praxis Precision Medicines, Inc..
Noam Epstein, MD Dr. Epstein has received personal compensation for serving as an employee of Praxis Precision Medicines.
Hong Sun, MD, PhD Dr. Sun has nothing to disclose.
Steven Petrou, FAHMS Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care.
Marcio Souza Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
Hannah Foster Ms. Foster has nothing to disclose.
Ping Li, MD Dr. Li has nothing to disclose.
Maggie Markgraf Ms. Markgraf has nothing to disclose.
Clio A. Rubinos, MD, MSCR Dr. Rubinos has nothing to disclose.
Jana Wold, MD Dr. Wold has nothing to disclose.
Maziar Eslami, MD Dr. Eslami has nothing to disclose.
Joaquim J. Ferreira The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial, Neurocrine, AbbVie, Biogen and Lundbeck. The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, AbbVie, BIAL, Biogen, Lundbeck . The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, BIAL, Nordic Infucare, ONO and SK Chemicals.
XIAOLI YAO, MD, PhD No disclosure on file
Azhar Said, MD Dr. Said has nothing to disclose.
Apurva H. Patel, MD Dr. Patel has nothing to disclose.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
Nora Nikprelevic, MD, MBBS Dr. Nikprelevic has nothing to disclose.
Jin-Tai Yu, PhD Prof. Yu has nothing to disclose.
Duygu Selcen, MD, FAAN Dr. Selcen has nothing to disclose.
Andrew Choma No disclosure on file